ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000952.1|Pristinamycin_2 # 1248 # 2081 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.772	BGC0000952.1|Pristinamycin_2 	1248	2081	-	Loose	500	28.1054	OXA-159	40.0	3001464	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCGCGCCCATCCTCGTCGCCACCCTCGACACCCGCGGCCCCGCCGCCACCCTCGGCACGATCACCCGCGCCGTGCGGGCCGCGGAGGCCGCCGGATTCGACGCCGTCCTGATCGACGACCGGGCCGCCGCCGGCGTCCAGGGCCGGTTCGAGACGACGACGCTGACCGCCGCGCTGGCCGCCGTCACCGAGCACATCGGCCTGATCACCGCCCCGCTCCCGGCCGACCAGGCCCCCTACCACGTGTCCCGGATCACCGCCTCGCTCGACCACCTCGCCCACGGCCGCACCGGCTGGCTCGCGAGCACGGACACCACCGACCCCGAGGGCCGCACCGGCGAACTCATCGACGTCGTCCGCGGCCTGTGGGACAGCTTCGACGACGACGCCTTCGTCCACGACCGCGCCGACGGCCTGTACTGGCGGCTGCCCGCCGTCCACCAACTCGACCACCAGGGCAGGCACTTCGACGTGGCCGGCCCCCTCAACGTCGCCCGCCCGCCGCAGGGCCACCCCGTCGTCGCCGTCACCGGCCCCGCCCTCGCCGCGGCCGCCGACCTCGTCCTGCTCGACGAGGCGGCCGACGCCGCCTCGGTGAAGCAGCAGGCACCGCACGCCAAGATCCTCCTGCCGCTGCCCGGCCCGGCCGCCGAACTGCCCGCCGACAGCCCCGCGGACGGCTTCACGGTGGCGCTCACCGGCTCCGACGACCCGGTCCTGGCCGCGCTCGCCGCCCGGCCCGGCCGCCCGGACCGCACCGCGGCCACCACCCTGCGCGAACGCCTGGGCCTGGCCCGCCCCGAGAGCCGCCACGCCCTCACCACCGCCTGA	MTAPILVATLDTRGPAATLGTITRAVRAAEAAGFDAVLIDDRAAAGVQGRFETTTLTAALAAVTEHIGLITAPLPADQAPYHVSRITASLDHLAHGRTGWLASTDTTDPEGRTGELIDVVRGLWDSFDDDAFVHDRADGLYWRLPAVHQLDHQGRHFDVAGPLNVARPPQGHPVVAVTGPALAAAADLVLLDEAADAASVKQQAPHAKILLPLPGPAAELPADSPADGFTVALTGSDDPVLAALAARPGRPDRTAATTLRERLGLARPESRHALTTA	MKKTLSRWRRGALALRLLGALASPVVFAMPGHAAEPAHSSAVRIAERADWGKYFADEGVKGTVIVLDGRTQTYQAYDAARAERRMSPASTYKIFNSLLALESGALDNEREVIPWDGKPRRVKAWNAALDLRNAFRVSCLPCYQVVSHKIPRQYAQAKLNEAGYGNRTIGRAAHAYWIDDSLQISAREQVDFLQRLATGALPFSARSQDIVRNISIVEANVDYVLHGKTGWFTEKKPDIGWWVGWLERDGNLTMIALNIDIQTDADAPKRARIVRNVLKDLKLI	97.88	gnl|BL_ORD_ID|3754|hsp_num:0	4824			633	693	cloxacillin; oxacillin; cefalotin
BGC0000952.1|Pristinamycin_3 # 2243 # 3448 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.679	BGC0000952.1|Pristinamycin_3 	2243	3448	+	Loose	750	26.5646	tet(33)	37.04	3000478	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAGCAGGTCAAGCGGGCTTTCAAGTACCGCTTTTATCCCACGGACGAGCAGGCGGCTGAGCTGTCCCGCACGTTCGGCTGTGTCCGCCTCGTGTACAACAAGGCGCTTGAGGGGCGCACGCGAGCCTGGTACGGCGAGCAGCGCCGGGTCTCCTACGTGCAGTCGTCCGCCGCGCTGACGGAGTGGAAGAAGACCGAAGAACTCGCCTTCCTCTCGGAGGTGTCCTCCGTCCCGCTCCAGCAGGCGCTGCGGCACTTGCAGACGGCGTTCGCCAACTTCTTCGCCAAGCGGTCGAAGTACCCGCGGTACAAGTCGCGGAAAAAGTCCAGGGCGTCGGCCGAGTACACCCGCAGCGCCTTCACGTGGCGTAACGGACAGCTCACGCTGGCGAAGACCGCGGAGCCCCTGGACATCCGCTGGTCCCGTCCCCTTCCCGAAGGGGCGGAGCCGACGACGGTGACCGTGTCCCGCGACCGTGCGGGCCGCTGGTTCGTGTCCCTGCTGTGCGAGGACACCATCACCCCCGCGCCCGCCACCACGGCGGCCGTCGGCATCGACGCCGGGATCACCTCCCTGGTGACCCTGTCCACCGGGGAGAAGATCACCAACCCCAAGCACGAGCGCCGTGACCGCGCCCGCCTCGCGAAGGCTCAGCGGGAGCTGTCGCGCAAGGCGAAGGGGTCGGCGAACCGGAAGAAAGCCCGCCGCAAGGTCGCCCGCGTCCACGCCCGGATCACCGACCGGCGCTGCGACTTCCTCCACAAGCTGTCGACTCGACTCGTCCGTGAGAACCAAACGGTCGTGATCGAGGACCTCACCGTCCGCAACCTGCTGAAGAACGGCAAGCTCGCGCGCGCCATCTCCGACGCGGCCTGGACGGAACTGCGCTCCATGCTGGAGTACAAGTGCGCCTGGTATGGGCGCGAACTCGTCGTGATCGACCGCTGGTTCCCCAGCTCCAAGCTGTGCGGAACCTGCGGCACGGTCCGCGGGAAGCTGCCGCTGAACGTCCGGGAGTGGACGTGCGACTGCGGCGCTGTGCATGACCGCGACGTGAATGCGGCACGCAACATCCTGGCCGCCGGGCTGGCGGCGTCGGCCTGTGGAGACGGTATAAGACCTCAACGGGAGTCCTCCCGGACGGGGCGGTCGTCGGTGAAGCAGGAACCCCAGCGGGCGACCGCTGGAATCCCCCGCCTTTAG	MQQVKRAFKYRFYPTDEQAAELSRTFGCVRLVYNKALEGRTRAWYGEQRRVSYVQSSAALTEWKKTEELAFLSEVSSVPLQQALRHLQTAFANFFAKRSKYPRYKSRKKSRASAEYTRSAFTWRNGQLTLAKTAEPLDIRWSRPLPEGAEPTTVTVSRDRAGRWFVSLLCEDTITPAPATTAAVGIDAGITSLVTLSTGEKITNPKHERRDRARLAKAQRELSRKAKGSANRKKARRKVARVHARITDRRCDFLHKLSTRLVRENQTVVIEDLTVRNLLKNGKLARAISDAAWTELRSMLEYKCAWYGRELVVIDRWFPSSKLCGTCGTVRGKLPLNVREWTCDCGAVHDRDVNAARNILAAGLAASACGDGIRPQRESSRTGRSSVKQEPQRATAGIPRL	MSSLTSARGSLATVLITASLDAAGMGLVMPILPALLHEAGVTADAVPLNVGVLIALYAVMQFIFAPVLGTLSDRFGRRRVLLVSLAGATVDYLVLATTSALSVFYIARAVAGITGATNAVTATVIADITPPHQRAKRFGLLSACYGGGMIAGPAMGGLFGAISPHLPFLLAALLSASNLALTFILLRETRPDSPARSASLAQHRGRPGLSAVPGITFLLIAFGLVQFIGQAPGATWVLFTEHRLDWSPVEVGISLSVFGIVQVLVQALLTGRIVEWIGEAKTVIIGCITDALGLVGLAIVTDAFSMAPILAALGIGGIGLPALQTLLSQRVDEQHQGRLQGVLASINSVTSIFGPVAFTTIFALTYINADGFLWLCAAALYVPCVILIMRGTAASPKFGSWASGDSM	98.53	gnl|BL_ORD_ID|1926|hsp_num:0	2046			768	849	tetracycline
BGC0000952.1|Pristinamycin_4 # 3462 # 4730 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.716	BGC0000952.1|Pristinamycin_4 	3462	4730	-	Loose	500	28.4906	CTX-M-226	34.0	3005649	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGACCGCACCCCGCCGGCGCATCACCCTCGCCGGCATCATCGACGGCCCCGGCGGCCATGTGGCCGCCTGGCGCCACCCGGCGACCAAGGCGGACGCCCAGCTCGACTTCGAATTCCACCGCGACAACGCCCGCACCCTCGAACGCGGCCTGTTCGACGCCGTGTTCATCGCGGACATCGTCGCCGTGTGGGGCACCCGCCTGGACTCCCTGTGCCGCACCTCGCGCACCGAGCACTTCGAACCGCTCACCCTGCTCGCCGCCTACGCCGCGGTCACCGAGCACATCGGCCTGTGCGCCACCGCCACCACCACGTACAACGAACCGGCGCACATCGCCGCCCGCTTCGCCTCCCTCGACCACCTCAGCGGCGGCCGGGCCGGCTGGAACGTCGTCACCTCCGCCGCACCGTGGGAGTCCGCCAACTTCGGCTTCCCCGAGCACCTGGAGCACGGCAAACGCTACGAGCGGGCCGAGGAGTTCATCGACGTCGTCAAAAAACTGTGGGACAGCGACGGCCGCCCCGTCGACCACCGCGGCACCCACTTCGAGGCCCCCGGCCCGCTCGGGATCGCCCGCCCCCCGCAGGGCCGCCCCGTCATCATCCAGGCCGGCTCCTCGCCGGTGGGACGCGAGTTCGCCGCCCGGCACGCCGAGGTCATCTTCACCCGGCACAACCGGCTCTCCGACGCCCAGGACTTCTACGGCGACCTCAAGGCACGCGTCGCCCGGCACGGCCGCGACCCCGAGAAGGTCCTCGTGTGGCCGACCCTCGCGCCGATCGTCGCCGCCACCGACACCGAGGCGAAGCAGCGCCTGCAGGAACTGCAGGACCTCACCCACGACCATGTCGCCCTGCGCACCCTTCAGGACCACCTCGGCGACGTCGACCTGAGCGCGTACCCGATCGACGGGCCCGTCCCCGACATCCCGTACACCAACCAGTCCCAGTCGACGACCGAGCGGCTGATCGGCCTGGCCAGGCGCGAGAACCTCAGCATCCGCGAGCTGGCCCTGCGGCTGATGGGCGACATCGTCGTCGGCACACCGGAGCAGCTCGCCGACCACATGGAGAGCTGGTTCACCGGCCGCGGCGCCGACGGCTTCAACATCGACTTCCCGTACCTGCCGGGCTCCGCCGACGACTTCGTCGACCACGTGGTGCCCGAACTGCAGCGCCGCGGCCTGTACCGCTCGGGCTACGAGGGCACCACCCTGCGGGCCAACCTCGGCATCGACGCCCCCCGGAAGGCAGGTGCAGCGGCTTGA	MTAPRRRITLAGIIDGPGGHVAAWRHPATKADAQLDFEFHRDNARTLERGLFDAVFIADIVAVWGTRLDSLCRTSRTEHFEPLTLLAAYAAVTEHIGLCATATTTYNEPAHIAARFASLDHLSGGRAGWNVVTSAAPWESANFGFPEHLEHGKRYERAEEFIDVVKKLWDSDGRPVDHRGTHFEAPGPLGIARPPQGRPVIIQAGSSPVGREFAARHAEVIFTRHNRLSDAQDFYGDLKARVARHGRDPEKVLVWPTLAPIVAATDTEAKQRLQELQDLTHDHVALRTLQDHLGDVDLSAYPIDGPVPDIPYTNQSQSTTERLIGLARRENLSIRELALRLMGDIVVGTPEQLADHMESWFTGRGADGFNIDFPYLPGSADDFVDHVVPELQRRGLYRSGYEGTTLRANLGIDAPRKAGAAA	MVKKSLRQFTLMATATVTLLLGSVTLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	145.02	gnl|BL_ORD_ID|3486|hsp_num:0	4555			30	168	
BGC0000952.1|Pristinamycin_5 # 4749 # 12434 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.760	BGC0000952.1|Pristinamycin_5 	4749	12434	-	Loose	1000	132.109	almE	26.07	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACCACACTCCAGACCCCAGGCGCGCAGAACCCCGCGACCGCCGGACCGGGGGCGGACGAGGCACGCCGCACACCGCTCACCGAGGAGCAGCTGGGACTGCTGCTCCAGCATCGCGCCGACCCCGCCGCCTCCCCGTACAACGTGCCCCTCGCCCTCGACCTGCGCGGCCCGCTCGACGCCGCCGCGCTCGAGGCGGCGCTCGGCCGGCTCGTCGCCCGCCACCCGATGCTGTCCGCGCGCGTCGCCGACGACGACCACGGCGACGGCCCGCCCTTCCTCGACATCGACCCCGGCCGCGCCCCCCGCCTGGAGCGCCGCACCGCCGCCGACGACGGCGCGGACGCCGGCACGCTGCTCGCCGAGGCCCGCCGCGAACTCGACCTGGAACGGGACGGCGTGCTGCGCGCCGTCCTCCTCGGCCACGGCCCCGAGCACCACACCCTGCTGCTCGTCGTCCACCACCTCGTCGTCGACGGCGAGTCCACCGGCCTGCTCCTCGCCGACCTGCTCGCCGCCTACGAGCACGGGGACGTCCCCGGCCCCGCCCCCGCCGCCTTCGCCACCTACGTCGGCGAACGCGCCCGCGAGGCCGAGAAGGACACCGCCGCCGCGGAGACGTACTGGCGCGAACACCTCGACGGCGCCGACCTGACCGTCGACGTCCCCCTCGACACCCCCGCCGGAGACGACGGGCGCCGCGAGGCGGCCGTACCGCTGGAACTGGACAGCCGGCTCTGGAGTGAGATCACCGCGTTCTCCCGCACCCACCGCGCCGGAGCCGCCGCCGTCCTGCTCGCCGCCTACCTCAAGGCCCTCGGCACGTACGGCCGGCAGAGCGCGCCCACCGTCGGCGTGCCGCTCGGCGCCCGCACCGACCCGCGCTACGACCGCACCGTCGGCTACTTCGTACGCACCCTCCTGGTGCGCGCCCCCGCCCAGGACGAGGACCTGACCGCCGCCGGGTTCGTCACCGGCGTGCAGCGGGAACTGGCCCGCGCCGTCGACCACTCGCGGCTGCCGTTCCCGCACATCGCCAAACTCGCCCCCCGCACCGGCTCCGGCGCCCCGTTCAACTGCACCTTCGTCCTGCACAGCTGGGCCGACGCCACCGCCGCCGCGACCGACGGCGTCGCACTGCGCGGCGGCCTGCGCGCCCACTGGCGCCAGGACGTGCCCACCCCGGGCCTGGGGCTGCTCACCCTGGAGCTGTACGAGGGCGACGGCCGGCTGCGCGGACGCCTCAAGTACGACGCCTCCCGCATCGAGGCCGCCACCGCCGAGGCGTTCACCGAACACGTCACCACCCTCGCCCGCCAACTGGTCCGCGAACCGGACGCCCCCGTGACCGGACTCGAGGGCATCGGCCCGCGCGCCCGCGCCACCCTCGACCACCTCAACGCCACCGACCACCCCGTCGCCGACACGGACATCGACACCCTGATCCGCGGCGTCGTCGAGGCCCGGCCGGACGCCGTCGCCGTCCGGTTCGCCGACCGCAGCTGGACCTACCGCGACCTGGACGCCCGCATCGAGGCGTACGCGGCCGGGCTCACCGCCCGCGGCGTGCGCGCCGGCGACCGGGTCGGCATCCTCCTGCCCCGCAGCGACGAGGCCGTCGCCGTGATGCTCGCGGTCCTGCGCACCGGGGCGGCCTACGTCCCCCTGGACGCCGCCCACCCCGAGGCGCGCCGCCGCCACATCGCCGACAGCAGCGGCATGCGGCTCGCGGTCGTGGACCCCTCGACGGCAGCGGCCTGCCCCCCGGGCCCGCAGCAGGTGCCGGCGGCCGAACTGGCCCAGCCCGGCACGGCGGCCGCGGTGCGCGGACCGGCCCCCTCCAGCGCCCTGCACATCCTCTACACCTCCGGCTCCACCGGCACCCCCAAGGGCGTCCAGCTCAGCCACCGCGCCCTGGTCACCGATGTGCTCGCCGCGATACGGCACTTCGGCATCGGCCCCGGCGACACGATGCTCCTCAAGGCGCCGTTCACCTTCGACGTCAGCGCCCACGAGATGCTCGTCGCCCTCGTCGCGGGCGCCCGGCTCGCCGTCGCACCGCCCGACGCGGAACGCGACCCCGACCTGCTGGCCGAGACCCTCGACCGGTACGGCGTCACGCTGCTGCACGCGGTGCCCTCCCAGCTCCGCCTGCTCCTGGAGGCGGAGAACTTCGGCGCCAACCGCAGCCTGCGCACCGTCGTCTCGACGGGCGAGTCCCTGCCCAACGAACTGCGCACCGCCTTCGAGGCCGCCCACCCGGCCCGGCTGCACAACGCCTACGGGCCGACCGAGACCTCCTACTCCACGGTCTTCTCCTGGGCCCGCGGCGACGACGCGTTCTGGACACGCCGCGCGGAGGTGCCGATCGGCGTGCCGTTCGACAACATCCGCTGCCACGTCCTCGACGAACACCAGCGGCCCCTGCCGCCCGGCGCGCCGGGCGAGCTGTGGATCGGCGGCGGCACCGTCTCCGACGGCTACATCGGCGACCCGGAACGCACCGCCGACCGCTACCGCACGCTCGACCTCGGCGGCCGCACCGAGACCGTCTACCGCACCGGCGACCTGGTCCGGCTGCTGCCGGGCGGCACGCTCACCCACCTGGGCCGCCTCGACGACCAGGTGAAGATCAACGGCAACCGGGTCGAACTCGGCGAGGTCCGGGCCGCGTTGCTGTGCCTCGACGGCGTCGAGGACGCCACGGTCCAGGCCGTCCGCCACACCCACGGCAGCCTCCAGATCGTGGCCCACGTGGTGGCTCCGGCGACGGACACGGCGGCGATCCGCCAGGCCCTGAAGCCCCTGCTCCCGTCCCACATGCTCCCGGCCCGCCTCCACCACGTCCCGCGCATCCCTCTCCTGCCCAACGGCAAGACCGACCGCCAGACCCTCGCCCGCCTGACCACGACGGCGGACGCCCCGGCGCCCGCGCCGGTCGCGGACGCCACCGTCCTGCCCACGGCGGGTGGTTCACCGCGGGAGGCGGTCACGGCCGCCGTCGACCGGGCGGCTTCGGCCGCCACCGCCCCGGCCCCGGCGCCCGCGCCGGCCCCGGCCGCCCACACCTCGCCCACAGCGGGTGGTTCACCGCAGGAGGCGGCCCCGGGCGCCGTCGACCGGGCGGCCATGGCGGCGGGGACCGCCCCGGCGTCCGCGCCGGTCGCGGACGCCACCGTCCTGCCCACGGCGGGTGGTTCACCGCGGGAGGCGACCCCGGGCGCCGTCGACCGGGCGGCTGTGGCCGCCACCGCGCCGGCCACGGCAGACGCCCCGGCCGCCGACACCCCGCTCGCATCGGGTGGTGCACCGCTGGAGGCGGCCACGGCCGCCACCGCCCCGGCGCAGCCGGTCGTCTCCCGGGCCCCCGACGGGGCCGGTGAGCCGGTGCCGGCCACCTCGCCCACGCCCACGCCCGCGCCTTCGGCGCAGGTGCTGGAGCGCGTGCGCGGCGTATGGGCGGAGCTGCTCGGGGACGCCGGGGACCAGGCGCAGTTCTTCGAGGCCGGCGGGGACTCCATCCTCGCCATGCAGCTCGTGTCCCGGCTGCGCCGCGCCGGGTTCACGCTCGCCATGCGCGACATCTACCGCAACCCCGTCCTGGCCGACCTCGCCGCGCACCTCGGCGCCGGGGTCCCGGACGCGCCGCAGGCCGACGAGAGCGGCGGCGACGGGACCCGGCCCGCCGCGCGGGCCGCCGGGCCGGTGTCACCGCTCGCGCCCGTGCAGTCGTGGTTCTTCCGGCACATCAGGACCGACCTCCACCAGTGGAACCAGTCCGTCCTGCTGGAGCTGAACGAAGCCGTCGACCCCACCGTCCTGCGGCTCGCCCTGCAGTCGGTCGTCGCCGCGCATCCCGCCCTGTCGGCCCGTTTCGACGAGGACCCGGACGACCCCGACGGCCCCGGCCGGCTCATGGTCCGCGCGGCACCGTTCACCGCCTACCCGGCACGGGAGGTGCTGTGGGAGCGGGACATCACCAGCGACCCGGAGCTCGACCGGGTGATGGAGGACCTCGAGCGCAGCCTGGACCCGCTGCGCGGCGTGCATGTGCGGGCCCTGCTCGCCCACGACCGGCGTTCCCCGGACGCCGCCCCGACCCATCTGCTGATCGCCGTCCACCACCTCGTCGTGGACGGGGTCTCCTGGCGCATCCTGCTGGAGGACCTCGAGCACGCCCTCGCCTCCCTCGCCGACGGGGCCCTGCCCGCCCTGCCCGAGGAGGCGTGCCGCTACGAGGACTGGGTCGCCTCACTGCCCGCCGTGGCCGCCCGGCCCGGCGAGGCCGACTACTGGCGCGCCCTCGCGGCGGCACGTGCCGAGGCCCAGACCCTGCTGCTGACCACGCCCGCGCCGGACGAGGAGCACATCCGCCGGGTCGAGTTCAGCCTCGACGAGGAGGCGACCGCCCGGCTCATCGGCCCGCTGCCGCGCCGGCTGGGCCTCCAGGTGCACCAGGTGATGACGGGCGCGTTCGCGCAGGCCCTCGCCCGCTGGCGGGGCAGCCGCGCCGTCACCTTCGACGTGGAGACCCACGGACGGCACGGCCGCGACGAACTGTTCCGTACCGTCGGCTGGTTCACCTCCATCCACCCCGTCGTCCTGGGCGCGGACCGCTCCGTGCACCCCGAGCAGTACCTCGCCCAGATCGGCGCGGCGCTGACCGCCGTACCGGACGGCGGCGTCGGCTTCGGCGCCTGCCGCGAGTTCTCCCCGGACGCCGGGCTGCGCACTCTGCTGCGTGACCTGCCGCCCGCCCTGGTGTGCTTCAACTACTACGGTCAGGCCGACCAGTTGAGCCCGAACGGCGGTTTCCGTATGTCGGGCCGTCCCATCCCGCGCGAGCACTCCGCCCGCTGCGAGCGCGTCTACGGCATCGAGGTGTACGGCATCGTCCACGGCGGCCGCCTGCGCATGGGCCTGACCTGGGTGCCGAGCCCGGCGGACGGTGTGGACGAGGCCGGCGTCGACGCGCTCGTGGAGCAGATGAGCTGGGTGCTGGCCACGCTCGCGGGCGCCGACCCGCACGCCGTGACCCCGGCCGAGATCACCGCGCCCGGCGCCACCGGCCCCGCCCCGCGCCCCGCCCGTCCCACCGCCCCTCCCGCCGTCCTCGCCCACAGCGGCGACGACGGGAGCGACCACGGCGGCGCCGGGGACGGCCCCGGGACCGTGCCGGTCACCCCCCAGCAGCACGGCCTGCTCCTGGACGCCCTCGCCCACCCCGGCACCGGCCGCTACGTGGAGCAGCTGTTCTGGCGCTGGCACGGCCCCCTGGACACCGACCGGTTCACCGCCGCCTGGCAGTCGGTGTTCGACCGCGAGACCGTGCTGCGGGCCTCCTTCGACTGGCAGGACGAGCCCTGCCTGGTCCTGCACGACCACGTCACCGCCGAGGTCACCCGCCACGCCGCGGGCCCCGCCGGCCCCGCCGACTTCGACGCGCTGATGGAACGCGACCGGCTGCGCGGCTTCGACCTGCGCACCCCCGGACTGCTGCGCGTCACCCTCGTCGACGACCCGGCGCCCGCCGACGGCCGAGAGCCGCTGTCGGTACGGATCCTGCTCACCTTCCACCACGTCCTGCTCGACGGCTGGAGCGTGTCCATCCTGCTCCAGGAGTTCTACCGCGCCTACCTCGCCGGTGGTGCGCTGCCCGGCGGCGAGCGGCGCCCCGACGTGCGCGACTACTCGCAATGGCTGTCCGAGCAGGACACCGCCCCCGCCCGGGAGTTCTGGTCCGACGCCGTCCCGGCCGCCGCGCCCGTCGTCCAGCCCGCCATCCCCGGCCCGGCGACCGGCCAGAGCGGCTCGGGCCGTGCGGAGTGCCGGCTCAGCGCCGCGGAGGCCGACCGGCTGCGCGCCTGGGCCGCGGCCCGCGCCGCCACCGAGTCCAGTGCCCTGCAGGCCGTGTGGGCGCTGCTGCTGTACCGGGCGGGCGGCACCAGCGGCCCGGCGCCGGTCGGTTTCGGTGTGACCGTCTCCGGCCGCGGCATCGCCCTCGACGCGGTCGAGCGGCTGCCCGGGCTGCTGATGAACTCGCTGCCCATGACCATCCAGGTCGACCCCGGCCACAGCCTTCCCCGGCTGCTGACGGAACTGCGCGACCAGGCTCTGGACATGGCGGCCTACGAGTGGGTCTCCACCGGCCAGATCCACGAGTGGAGCGGCCGCAGGCCGGGCGAGAAGCTCGTCGAGAGCCTCATCGTCTTCGAGAACTACCCGCGCTCCTCCGGCGACCTGGAATCCGCCCTCGCCGCCCAGGGCATCCGCGTCGAACTGCCCGACGCGGCCGGCTCGCAGACCGCGTTCCCCGTCACCCTGCTCGCCTACCGCGACGTGGACGGCAGCCTGGTCCTCGCCGCCGTCCACGACCGCGGCCGGATCGCCGACGCCGAGGCGGAGAAGCTGGTCGCCCAGTGCGCCCGGCTGCTGCGCGAACTGCCCGCCACCGACGACGAGGCCACCACCGTCGCCGACGTGCTGGCCACCGTCACCGACGCGGACCTGCCGCGCATGGCCGAACGCTCCGAGCAGCCGGACGACACCGGCGAAACGCCCGCCGACTGGCCCGAGGGCCCGGAGGCGGACTTGGTCAGGCAGGCGTGGCAGACCGTCTTCGGCACCACCGACGTCGACCCCGGCGAGCACTTCTTCGAAGCCGGCGGCCACTCCCTGCTGGCCATGCGGCTGCTGCGCGAGATCAGCCTGCGCACCGGCCGCACCCTGCGCCTGGACGAACTGCTCGCCAACCCCCGGGCCGGCATGCTCGCCCGCCTCCTCGCCGAGACCCCGCACGACGGCGCGGACGCCGACGGCGCCGCATCGGTCCTCGTACCGCTGCGGCCCGCCCGGCAGCCCGGCGCCGGCACCGTCCACCTCGTCCACCCCCCGGGCGGTCAGGTCGCCTGCTACGCGCAGCTCGCCGCCGGCTACCCCGGCCCCGAGGCGCTCGTCGGCATCCGCGACCCGCGCGTCGACGACCCCGAGCCCGAGTACCGCTCCACGGAGCAGCTGGCAGAGCACTACCTCCAGGCGCTCGCCCCCGCCCTGGAATCGGGGGAGCGGATCGTGCTGGGCGGCTTCTCCGGCGGCGGCGTCATCGCCTACGAGATCGCCCAGCGGATCACCGCGCAGGGCGGCACACCGCCGCTGGTGGTGATGGTCGACGCGGGCGCGCCGGACGGTGAACTGACCGACGCGGAGGCCGACGGCTCGTTCGCCGGTCAACTGCGGGCGGTCGCCGAAGGCCGCACCCCCGACCCCGCGTCCACCACCACCGACCCCGAACCCCCCGCCACGGACGACGACCGGGCCGCCGCCACCGCGGAGCCCGCCGGGTCGGCCGCCTACCTCGCCGAGATCTCCCAGATCGCCGAATGGATGCGCGGCGACGGCGGCGGCGACCTCGTCGCGCTGATGCGCGACAGCGTCGAGGCGATCCAGCGCTACCGGCCCTGCTCCTACGCCGGTCCCGTCGTCGTGCTGCGCGCGGGGGACACCAGCTTCGGCAAGGGCACCGACTACGACGAGAGCGACCGGTTCCACGGCCGTCCCGGCCTCGGCTGGGAGGACCACGTCGAAGACCTCACCATCCGGGTCGTGCCGGGCAACCACGTGACCATGCTGACCGGCGACAACGTGCGCAGCCTCGCCCGGATCCTGGCGTCCGCCGTCAAGAACTGA	MTTLQTPGAQNPATAGPGADEARRTPLTEEQLGLLLQHRADPAASPYNVPLALDLRGPLDAAALEAALGRLVARHPMLSARVADDDHGDGPPFLDIDPGRAPRLERRTAADDGADAGTLLAEARRELDLERDGVLRAVLLGHGPEHHTLLLVVHHLVVDGESTGLLLADLLAAYEHGDVPGPAPAAFATYVGERAREAEKDTAAAETYWREHLDGADLTVDVPLDTPAGDDGRREAAVPLELDSRLWSEITAFSRTHRAGAAAVLLAAYLKALGTYGRQSAPTVGVPLGARTDPRYDRTVGYFVRTLLVRAPAQDEDLTAAGFVTGVQRELARAVDHSRLPFPHIAKLAPRTGSGAPFNCTFVLHSWADATAAATDGVALRGGLRAHWRQDVPTPGLGLLTLELYEGDGRLRGRLKYDASRIEAATAEAFTEHVTTLARQLVREPDAPVTGLEGIGPRARATLDHLNATDHPVADTDIDTLIRGVVEARPDAVAVRFADRSWTYRDLDARIEAYAAGLTARGVRAGDRVGILLPRSDEAVAVMLAVLRTGAAYVPLDAAHPEARRRHIADSSGMRLAVVDPSTAAACPPGPQQVPAAELAQPGTAAAVRGPAPSSALHILYTSGSTGTPKGVQLSHRALVTDVLAAIRHFGIGPGDTMLLKAPFTFDVSAHEMLVALVAGARLAVAPPDAERDPDLLAETLDRYGVTLLHAVPSQLRLLLEAENFGANRSLRTVVSTGESLPNELRTAFEAAHPARLHNAYGPTETSYSTVFSWARGDDAFWTRRAEVPIGVPFDNIRCHVLDEHQRPLPPGAPGELWIGGGTVSDGYIGDPERTADRYRTLDLGGRTETVYRTGDLVRLLPGGTLTHLGRLDDQVKINGNRVELGEVRAALLCLDGVEDATVQAVRHTHGSLQIVAHVVAPATDTAAIRQALKPLLPSHMLPARLHHVPRIPLLPNGKTDRQTLARLTTTADAPAPAPVADATVLPTAGGSPREAVTAAVDRAASAATAPAPAPAPAPAAHTSPTAGGSPQEAAPGAVDRAAMAAGTAPASAPVADATVLPTAGGSPREATPGAVDRAAVAATAPATADAPAADTPLASGGAPLEAATAATAPAQPVVSRAPDGAGEPVPATSPTPTPAPSAQVLERVRGVWAELLGDAGDQAQFFEAGGDSILAMQLVSRLRRAGFTLAMRDIYRNPVLADLAAHLGAGVPDAPQADESGGDGTRPAARAAGPVSPLAPVQSWFFRHIRTDLHQWNQSVLLELNEAVDPTVLRLALQSVVAAHPALSARFDEDPDDPDGPGRLMVRAAPFTAYPAREVLWERDITSDPELDRVMEDLERSLDPLRGVHVRALLAHDRRSPDAAPTHLLIAVHHLVVDGVSWRILLEDLEHALASLADGALPALPEEACRYEDWVASLPAVAARPGEADYWRALAAARAEAQTLLLTTPAPDEEHIRRVEFSLDEEATARLIGPLPRRLGLQVHQVMTGAFAQALARWRGSRAVTFDVETHGRHGRDELFRTVGWFTSIHPVVLGADRSVHPEQYLAQIGAALTAVPDGGVGFGACREFSPDAGLRTLLRDLPPALVCFNYYGQADQLSPNGGFRMSGRPIPREHSARCERVYGIEVYGIVHGGRLRMGLTWVPSPADGVDEAGVDALVEQMSWVLATLAGADPHAVTPAEITAPGATGPAPRPARPTAPPAVLAHSGDDGSDHGGAGDGPGTVPVTPQQHGLLLDALAHPGTGRYVEQLFWRWHGPLDTDRFTAAWQSVFDRETVLRASFDWQDEPCLVLHDHVTAEVTRHAAGPAGPADFDALMERDRLRGFDLRTPGLLRVTLVDDPAPADGREPLSVRILLTFHHVLLDGWSVSILLQEFYRAYLAGGALPGGERRPDVRDYSQWLSEQDTAPAREFWSDAVPAAAPVVQPAIPGPATGQSGSGRAECRLSAAEADRLRAWAAARAATESSALQAVWALLLYRAGGTSGPAPVGFGVTVSGRGIALDAVERLPGLLMNSLPMTIQVDPGHSLPRLLTELRDQALDMAAYEWVSTGQIHEWSGRRPGEKLVESLIVFENYPRSSGDLESALAAQGIRVELPDAAGSQTAFPVTLLAYRDVDGSLVLAAVHDRGRIADAEAEKLVAQCARLLRELPATDDEATTVADVLATVTDADLPRMAERSEQPDDTGETPADWPEGPEADLVRQAWQTVFGTTDVDPGEHFFEAGGHSLLAMRLLREISLRTGRTLRLDELLANPRAGMLARLLAETPHDGADADGAASVLVPLRPARQPGAGTVHLVHPPGGQVACYAQLAAGYPGPEALVGIRDPRVDDPEPEYRSTEQLAEHYLQALAPALESGERIVLGGFSGGGVIAYEIAQRITAQGGTPPLVVMVDAGAPDGELTDAEADGSFAGQLRAVAEGRTPDPASTTTDPEPPATDDDRAAATAEPAGSAAYLAEISQIAEWMRGDGGGDLVALMRDSVEAIQRYRPCSYAGPVVVLRAGDTSFGKGTDYDESDRFHGRPGLGWEDHVEDLTIRVVPGNHVTMLTGDNVRSLARILASAVKN	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	460.61	gnl|BL_ORD_ID|4935|hsp_num:0	5928			105	1635	colistin A; colistin B
BGC0000952.1|Pristinamycin_6 # 12768 # 14081 # -1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.726	BGC0000952.1|Pristinamycin_6 	12768	14081	-	Loose	700	27.335	PDC-203	30.16	3006582	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GTGACCGCGGGCCTGCTCGAGGCGCCCGGGCTGGCCGCGGCCCCGCTGACCACCGCCGACCTGCACGCCAGCCTCACCGATCCGGCCCTGACCTCGATGACCCTCCTCAACGAGATCACCGGCAACTACCCCCAGGCCGTGTCGTTCGCCGCGGGCCGGCCCTACGAGGGCCACTACGACACCGAGGCCCTCCACCACCACCTGCGGCGCTTCACCCGCCACCTCGAGCAGGACCTCGGCCACAGCGAGGAACAGGTACGCCGCACCCTGTTCCAGTACGGGCCCACCAAGGGCGTCATCAACGACCTCCTCGTACGCCAGCTGCACACCGACGAACACATCACCGCCGACCCCGAAGCGGTCCTGGTCACCACCGGCTGCCAGGAGGCCATGGTCCTGCTGCTGCGCGCCCTGCGCCGCGACGCACGCGACACCGTCCTCGCCGCCGCCCCCACCTACGTGGGATTCACCGGGGCCGCCCGCCTCACCGAAATGACGGTCCGCCAGGTCCCCGAAGGCCCCGGCGGACTCGACGCCGCGGACCTCGCCCGCGCCGTGCGCGCCGCCCGCGCCGAAGGACTGCGACCGCGCGCCTGCTACGTCGTCCCCGACTTCTCCAACCCCGGCGGCGCCCGCATGTCGGAGGCCGACCGCCGCCGGCTGCTGCACGCCGCCGACGAGCTGGACATCCTCCTCATCGAGGACAACCCGTACTCGATGTTCCACGACGGCCAGGGCCGGCCGCCGACCCTGAAGTCGATGGACCGCTCCGGACGCGTCGTCTACATCGGCTCGTTCGCCAAGACCGCCTTCCCCGGCGCCCGCATCGGCTACGTCGTCGCCGACCAGCCCGTCGCCGAGGGCGGCCTGCTCGTCGACCAGCTCGCCAAGCTCAAGAGCATGCTCACCCTCAACACCTCGGCCCTCGCCCAGGCCGTCATCGGCGGCCTGCTCCTCGAGCACGGCTGCAGCATGGAACGAGCCTGCGCCCGCGAGGCCGCCGTCTACCGCACCAACCTGAACGTCCTCCTCGACGGCCTCGCCACCCGCTTCCCGCCCGGCAGCGGCGTCACCTGGAACACCCCCGCCGGCGGCCTCTTCGCCGTGCTGAGCGTGCCGTTCACCGCCGACGAAGCGGCCCTGGAGGAGTCGGCGGGCCGCTTCGGCGTCCTGTGGACACCGATGTACCACTTCTACGCGGGCACCGGCGGCCTGACCCAACTGCGCCTGTCCTACAGCGTGCTGACCCCCGACGAGATCACCACCGGCCTGGACCGCCTCGCCGCCTTCGTCGCCGCCCGCACGCCCCGCTGA	MTAGLLEAPGLAAAPLTTADLHASLTDPALTSMTLLNEITGNYPQAVSFAAGRPYEGHYDTEALHHHLRRFTRHLEQDLGHSEEQVRRTLFQYGPTKGVINDLLVRQLHTDEHITADPEAVLVTTGCQEAMVLLLRALRRDARDTVLAAAPTYVGFTGAARLTEMTVRQVPEGPGGLDAADLARAVRAARAEGLRPRACYVVPDFSNPGGARMSEADRRRLLHAADELDILLIEDNPYSMFHDGQGRPPTLKSMDRSGRVVYIGSFAKTAFPGARIGYVVADQPVAEGGLLVDQLAKLKSMLTLNTSALAQAVIGGLLLEHGCSMERACAREAAVYRTNLNVLLDGLATRFPPGSGVTWNTPAGGLFAVLSVPFTADEAALEESAGRFGVLWTPMYHFYAGTGGLTQLRLSYSVLTPDEITTGLDRLAAFVAARTPR	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYPPGSQRRYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	110.08	gnl|BL_ORD_ID|4272|hsp_num:0	5342			402	567	
BGC0000952.1|Pristinamycin_7 # 14078 # 14296 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.694	BGC0000952.1|Pristinamycin_7 	14078	14296	-	Loose	400	22.3274	MAB	90.0	3007180	protein homolog model	n/a	n/a	cephalosporin; penam; penem	antibiotic inactivation	class A Mycobacterium abscessus beta-lactamase	ATGAGCAACCCCTTCGAGGACGCCGAGGGCACCTTTCTCGTCCTGGTCAACCACGAGGGCCAGTACTCGCTCTGGCCGTCCTTCGCCGAGGTCCCGGCCGGCTGGACCGTCGCCCTGCCGGCCACCGACCGCGAGAGCGCCCTGGCCCACATCACCGACCGGTGGACCGACATGCGGCCCCAGAGCCTCATCGACGCCATGAACGGCACGGCGGCGTGA	MSNPFEDAEGTFLVLVNHEGQYSLWPSFAEVPAGWTVALPATDRESALAHITDRWTDMRPQSLIDAMNGTAA	MISRRALLVGGVSAVGVVAAGCSRNGNRRPAPDELASLEKDFGGRIGVYALDTGSGDTVGHRADERFLMCSTVKTFIVSAILRRRLSEPGLLDQRIQYTQSDVLEWAPITSQHVSTGMTVSELCDATLRYSDNTGANLLITQLGGPKETEKFVRSLGDNVTRMDRTEVQLNIPDGDLDTSTPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKGETNDIAVIWPPGRAPIVMAVLTVPEDPTSTKGKPTIAAATRIVLRAFGA	24.91	gnl|BL_ORD_ID|4810|hsp_num:0	5799			663	693	ceftazidime; cefuroxime; amoxicillin; cefalotin; ticarcillin
BGC0000952.1|Pristinamycin_9 # 15144 # 16184 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.730	BGC0000952.1|Pristinamycin_9 	15144	16184	-	Loose	710	25.409	efrB	37.14	3003949	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCCCACCGACCCCGCCGCCGCCCGCACCGGCAAGAGCACCGCCGACGGCACCGTCACCATGGCCAAAGCCCTCAACACCGCCCTGCGCGACGCCCTGCGCGCCGACGAGAACACCCTCGTCTTCGGCGAGGACGTCGGCACCCTCGGCGGCGTCTTCCGCGTCACCGACGGCCTGGCCCGCGAATTCGGCGACGACCGCTGCTTCGACACCCCGCTCGCCGAATCCGCCATCATCGGCACCGCCGTCGGCATGGCCATGTACGGCTACCGGCCCGTCGTCGAGATGCAGTTCGACGCCTTCGCCTACCCCGCCTTCGAACAACTCGTCAGCCACGTCGCCAAGTTCCGCGCCCGCACCCGCGGCCAACTGCCGCTGCCGCTGACCGTCCGCATCCCCTACGGCGGCGGCATCGGGGGAGTGGAACACCACAGCGACTCCTCCGAGATCTACTACATGGCCACCCCCGGCCTCACCGTCGTCACCCCCGCCACCGTCGCCGACGCCTACTCCCTGCTGCGCCGCTCCATCGACTGGCCCGACCCCGTCGTCTTCCTCGAACCCAAACGCCTGTACTGGCACAAGGAGAAGACCGGGCTGCCCACCGACACCGGCCCGCTGGGCTGGGCCGCCGTCCGCCGCCGCGGCACCGACGCCACCCTCGTCACCTACGGCCCCGCCCTGCCCGCCGCCCTCGCCGCCGCCGAGGCCGCCGCGGAGAGCGGCCTGAGCCTGGAGGTCATCGACCTGCGCACCCTCGCCCCCTTCGACGAGGAGACCGTCGCCGCCAGCGTCGACCGCACCGGCCGCGCCGTCGTCGTCCACGAGGCCCACGGCTTCGCCGGCCCCGGCGCCGAGATCGCCGCCCGCATCACCGAACGCTGCTTCTACCACCTGGAAGCACCCGTACGCCGCGTCACCGGCTTCGACGTGCCCTACCCCGCACCCCTCCTCGAAAGCCACTACCTGCCCGACGTCCAGCGCATCCTGGACGCCGTCGCCACCCTGGAGTGGCCCGCCCGCCGGACGGCCGCCGCATGA	MPTDPAAARTGKSTADGTVTMAKALNTALRDALRADENTLVFGEDVGTLGGVFRVTDGLAREFGDDRCFDTPLAESAIIGTAVGMAMYGYRPVVEMQFDAFAYPAFEQLVSHVAKFRARTRGQLPLPLTVRIPYGGGIGGVEHHSDSSEIYYMATPGLTVVTPATVADAYSLLRRSIDWPDPVVFLEPKRLYWHKEKTGLPTDTGPLGWAAVRRRGTDATLVTYGPALPAALAAAEAAAESGLSLEVIDLRTLAPFDEETVAASVDRTGRAVVVHEAHGFAGPGAEIAARITERCFYHLEAPVRRVTGFDVPYPAPLLESHYLPDVQRILDAVATLEWPARRTAAA	LDTCRIFRRNAKSPVNIAKHAKFIRRLKWLCSENMTGFSVLKLYVRKKKPLKGFKQVNHRFKWFGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQPMGNITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPEKPLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSVFGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHR	95.58	gnl|BL_ORD_ID|2183|hsp_num:0	2422			414	519	erythromycin; ciprofloxacin; rifampin
BGC0000952.1|Pristinamycin_10 # 16184 # 17242 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.761	BGC0000952.1|Pristinamycin_10 	16184	17242	-	Loose	400	32.3426	IMP-16	20.83	3002207	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGACCGTGCTCGACGCCCCCGCCGCCCCGCCGCCCGCCGCACCGGCCGGCCCGCCGCTGCCCGCCGCGACCGCGCTCGCGCTGTACCGGGCCATGGTCACCGGCCGCGCCTTCGACCGGCAGGCCACCGCCTTCACCCGGCAGGGCCGCCTCGCCGTCTACCCCTCCTCCCACGGCCAGGAGGCCTGCCAGACCGCGTCCGTCCTCGCGCTGCGCCCCACCGACTGGCTCTTCCCCACCTACCGCGAGAGCGTCGCCCTGCTCACCCGCGGCATCGACCCGGTGGAGGTCCTGACCCTCTTCCGCGGCGACCGCCACTGCGGCTACGACCCGCACGCCCACCGCACCGCCCCCCAGTGCACCCCACTGGCCACACAGTGCCTGCACGCCGCCGGACTCGCCGACGCCGCCCGCATGCGCGGCCACGACACCGTCGCCCTCGCCTACATCGGCGACGGTGCCACCAGCGAGGGCGACTTCCACGAAGCCGTCAACTACGCGGCCGTACGCCGCGCGCCCGTCGTCTTCCTGATCCAGAACAACCAGTACGCGATCAGCGTCCCGCTCGCCAAACAGACCGCCGCCCGCACCCTCGCCGACAAGGCCGCCGGCTACGGCGCCGCCGGCGTGCGCATCGACGGCAACGACGCCGCGGCCGTCCACACCGCCGTCGCCCGGGCCGCGCACCGCGCCCGCACCGGCGGCGGCCCCACCGTCGTCGAAGCCCTCACCTACCGCATCGAGGCCCATACCAACGCCGACGACGACACCCGCTACCGCAGCGCGGAAGAGGTCGCCGCCTGGGCGGACAAGGACCCCGTCGCCCGCCTCGAGCACCGCCTCCTCGCCGACGGCGTCCTCGACGAGGACACCCTCGCCGGCATCACCCGCGAGGCACAGGACCTCACCGCCCGCCTGCGCCGCACCTTCGCCTCCCCGCCCCGGCGCGACCCGGCCGAGATGTTCCAGCACGTCTACCACCAGCCGCCGCCCCACCTCAGGTCCCAGGCCGCCCTGCTCGCCGCGGAGACCGCCGCCGCGACGGGGGAGGACGCCTGA	MTVLDAPAAPPPAAPAGPPLPAATALALYRAMVTGRAFDRQATAFTRQGRLAVYPSSHGQEACQTASVLALRPTDWLFPTYRESVALLTRGIDPVEVLTLFRGDRHCGYDPHAHRTAPQCTPLATQCLHAAGLADAARMRGHDTVALAYIGDGATSEGDFHEAVNYAAVRRAPVVFLIQNNQYAISVPLAKQTAARTLADKAAGYGAAGVRIDGNDAAAVHTAVARAAHRARTGGGPTVVEALTYRIEAHTNADDDTRYRSAEEVAAWADKDPVARLEHRLLADGVLDEDTLAGITREAQDLTARLRRTFASPPRRDPAEMFQHVYHQPPPHLRSQAALLAAETAAATGEDA	MKKLFVLCIFLFCSITAAGESLPDLKIEKLEDGVYVHTSFEEVNGWGVVTKHGLVFLVNTDAYLIDTPFAAKDTEKLVNWFVERGYKIKGSISSHFHSDSSGGIEWLNSQSIPTYASELTNELLKKNGKVQAKNSFSGVSYWLLKNKIEIFYPGPGHTQDNVVVWLPEKKILFGGCFVKPYGLGNLDDANVEAWPHSAEILMSRYGNAKLVVPSHSDVGDASLLKLTWEQAVKGLKESKKPSQPSN	143.09	gnl|BL_ORD_ID|796|hsp_num:0	862			93	369	
BGC0000952.1|Pristinamycin_11 # 17239 # 18645 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.736	BGC0000952.1|Pristinamycin_11 	17239	18645	-	Loose	275	25.7942	AAC(6')-32	45.0	3002586	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGCGCACACCGACCCTCGCCGCCGAGGCCCCGGCGACCGACGCCGCCCCCGCCGTCCTCCTGCGTGCTCTGCCCGCCCGGCCACCCGCCCTGACCGGCGAGTTCACCAAGGACCGGGCGGCCGTCACCGCCTACCTCGACACCACCATGCGGCTCATCGCCGACCTGCCGCCGCGCACCGAACGCGACCCCGACCGGCAGCGCGACGCGGCCGCCGTCCACGACGGCGCCCACACCCTGCGCCACCGCTTCCTGGCCACCCACGCCGAACGGGTCTACGCCGAACTCACCGACGGCCTCACCCGCACCCCGCGCCTGGACGAACTGACCGCCCTCGCCGCCCGCCACTTCCCCGGCCTGGTCCCCACCCCCGCCCAACTGGCCGACGACGCACGCCACATGCAGCGCAACAAGGAAGGCTGGGAGATCGCCGTCGGCATCTTCTTCCAGGCCGTCCTCAGCGCCCCCGCCGCCGGCAACCACCTGCTGCGCTCCATGCTGCGCCCCACCACCCGCGCCCGGGCCGCCCTGCTGGACTACCAGCTCACCGGCCGCGCCGACCTGGGCATCGCCACCGTCACCCGCCGCGACGGCATCGCCCACCTCGAACTGTGCAACGACGAGTTCCTCAACGCCGAGGACGACGCCGCCGTCGAAGCCCTGGAGACCGGCTGCGACCTGGTGCTCCTGGACCCCGCCAGCCACGTCGGCGTCCTGCGCGGCGCCGCCCAGACCCACCCCGCCCACGCCGGCCGCCGCGTCTTCAGCGCCGGCATCAACCTCACCCACCTCTACCACGGCGACATCTCCCTCCTCGGCTTCCTGCTGCGCCGCGAAGCCGGCTACATCGCCAAGTTCGTCCGCGGCCTGTGCCTCGAGGACGGCACGGGCGACACCGGCGACAACTGGTGGCCCGACGCCGACAAGCCCTGGGTCGGCGCCGTCGACGCCTTCGCCATCGGCGGCGGCCTGCAGATCCTGCCCGTCATGGACCGCGTCGTCGCCGCCGACGACGCCTGGTTCAGCCTCCCCGCCATGGAAGAGGGACTGGTGCCCGGCGTCTCCAACCTGCGCCTGCTGCACCCGGCCGGCTCCCGCCTCACCCGACGCCTCATCTTCTGGGGCCACAAACTGAACGCCCGCGACCCCGAAGCCGCCGTGATCGTCGACGAGACCGCCCCCGCCGACACCATGGACAGCGCCGTCGAACGCGCCGCCCAGCACCTCGACCACCCCGCCGTCGGCGCCAACCGGCGCATGCTCAACCTCGTCGAGGAACCCGCCGACCTCTTCCGCCGCTACCTCGCCCGGTACGCCTACGAACAGGCCCGCCTGCTCCACAGCCCCGCCCTCATCAGCACCCTCGAACGCACCTGGATCAACCGGAACCGCGGCGGATCCCGATGA	MRTPTLAAEAPATDAAPAVLLRALPARPPALTGEFTKDRAAVTAYLDTTMRLIADLPPRTERDPDRQRDAAAVHDGAHTLRHRFLATHAERVYAELTDGLTRTPRLDELTALAARHFPGLVPTPAQLADDARHMQRNKEGWEIAVGIFFQAVLSAPAAGNHLLRSMLRPTTRARAALLDYQLTGRADLGIATVTRRDGIAHLELCNDEFLNAEDDAAVEALETGCDLVLLDPASHVGVLRGAAQTHPAHAGRRVFSAGINLTHLYHGDISLLGFLLRREAGYIAKFVRGLCLEDGTGDTGDNWWPDADKPWVGAVDAFAIGGGLQILPVMDRVVAADDAWFSLPAMEEGLVPGVSNLRLLHPAGSRLTRRLIFWGHKLNARDPEAAVIVDETAPADTMDSAVERAAQHLDHPAVGANRRMLNLVEEPADLFRRYLARYAYEQARLLHSPALISTLERTWINRNRGGSR	MSPSKTPVTLRLMTERDLPMLHAWLNRPHIVEWWGGEEERPTLHEVVKHYLPRVLAEEAVTPYIAMLGDEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQFLSNHTQLNQGLGTKLVQALVELLFSDPTVTKIQTDPAPNNHRAIRCYEKAGFVQQNVITTPDGPAVYMVQTRQAFERVRSAA	254.35	gnl|BL_ORD_ID|1443|hsp_num:0	1577			246	306	amikacin; tobramycin; gentamicin
BGC0000952.1|Pristinamycin_12 # 18663 # 33209 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.746	BGC0000952.1|Pristinamycin_12 	18663	33209	-	Loose	1000	124.405	almE	28.29	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACCCGGTCCGGACTCGCCGACGTCCTGCCCCTGTCCCCGCTCCAGGAAGGCCTCCTCTTCCAGGTCACCTACGGTGCCGAGACCCACGGCCCGGACGTCTACACCGTCCAGATGGTCTTCGAGCTGCGCGGCCCCCTCGACGAGGACGGCCTGCGGGCCGCCGCCGCGGCCCTGCTGCGCCGCCACCCCAACCTGCGCGCCGGGTTCTGGCAGCAGGGCGTCGAACGGCCCGTCCAGTTCGTGCCGAACGAGGTGCCGCTGCCCTGGCACACCCGCGACTTCACCGCACTGGGCGAGAGCGACCGTGAGCGGGCCGTCGAGGCGTACGTCACCGCCGACCGTGCCGAACGCTTCGACCCGGGCGCCCCGCCGCTGATCCGCTTCGCCCTGCTCGGCCTCGCCGCCGACCACCACAAACTCGTCCTGACCACCCACCACCTGCTCCTCGACGGCTGGTCGATGCCGCTGCTCGTACGGGAGCTGTTCACCCTCTACGGGCAGCGCGGCGACGACGCGGGCATGCCCCCCGTCACCCCCTACCGCGCCTACCTGGCCCACCTCGCCGGCCGTGACGACGACGCCGCCCGCGCCGCGTGGCGGACCGCCCTCGCGGACCTGGAGGAGCCGAGCCTCGTCGCGGGCGCCGGAGCAGGCCGCGGCGCCGCCGACGGCTCCGCCCTGCCCGGCCAGATCTGGCACGAGATCGACGCCGCGACCACCGCCGGGCTCACCGCGCTGGCCCGCTCGTGCAACATCACCCTCAACACCCTGGTGCAAAGCGCCTGGGCACTGCTGCTCGGCCGCCAACTGGGCCGCGACGACGTCGTGTTCGGCGCGACCGTCGCCCACCGCCCGCCGGAGATACCCGGCATCGAGTCGACCATCGGCATGTTCATCAACACCCTGCCGGTCCGCGTCCGCGTCCGGCCCGCCGAGACACTCGGCGACCTGCTCGGCCGGGTGCAGCGGGAACAGGCCGCCCTCATCGAGCACCGGCACCTGTCCCTCACCGACATCCGCTCCACGACCGGCACCGGTGAACTCTTCGACACCGTCGTCGTGTTCGAGAACTACCCCCTCGACCCGGCCGTCCTGCGCGCCGAGGCCCGCGGACTGCGCCTCGCGGGCTTCGAGGTTTCCGACGCCACCCACTACCCGCTGAGCCTGCTCGCCATCCCCGGCGAGAGTCTCCGCTTCCGCCTCGACCACCGGGGCGACGTCCTGGACGAGGCGGGCGCCCGGCTGCTGCTCGAGCGCCTCGACACGCTCCTCACCGACATCGCGGAGCACGGCGCCGACCTGCCCGTCGGCCGCCTCGACCTGCTGTCCGCCGCCGAACGCCACCAGGTCCTCGAGGAGTTCAACGACACCGGCCTGCCCGCCGAGGACGCCACACTCGCCGCCCTCTTCGAGGCACAGGCCGCCCGCACCCCCGACACCACCGCCCTCCTCGTGGGCGGCCGGTCACTGACCTACGCCGAACTCAACGCACGCGCCAACCGGCTCGCCCGCCACCTGGTCACCCTCGGCGCAGGACCCGAACAGATCGTCGCCGTCAAGCTGGAACGCTCCCTCGACCTGTACGTGGCGCTGCTCGCCGTCCTCAAGACCGGCGCCGCCTACCTGCCCGTCGACACCGCCTACCCGGCCGAACGCATCGCGTTCATGATGGACGACGCCCGCCCCGCCGTGGTCCTCACCGGCGAGGACACGGGCCAGGACCTGAGCGGCTACGACGACACCGACCTCACCGACGCCGACCGCACCGCGCCCCTGCTGCCCGCGCACCCCGCGTACGTCATCTACACCTCCGGCTCCACCGGCACCCCCAAGGCCGTCGTCATGCCCGGCGCCGCCCTGGTCAACCTGCTGGCCTGGCACCGCCGCGAGATACCCGGCGAGGCGGGCGCCCCCGTCGCCCAGTTCACCACCATCGGCTTCGACGTCGCCGCCCAGGAGATCCTCGCCACCTGGCTGCACGGCAAGACCCTCGCCGTACCGTCGCAAGAGGTGCGCCGCAGCGCCGAACAGCTGGCCGCCTGGCTGGACGAACAGCACGTCAGCGAGCTGTACGCACCGAACCTCGTCATCGAGGCCCTCGCGGAGGCCGCCGCGGAGGCCGGCCGCACCCTGCCCGCCCTGCGCCACATCGCCCAGGCCGGCGAGGCCCTCACCCTCACCCGCACCGTGCGCGAGTTCGCCGCCGCCGTGCCCGGCAGGCAACTGCACAACCACTACGGGCCCGCAGAGACCCATGTGATGACCGGCACCGCCCTGCCCGAGGACCCGGCCGCCTGGAGCGAGCACGCCCCCCTCGGCCGGCCCGTCTCCGGCGCCCGCGTGTACGTCCTGGACAGCGCACTGCGCCCGGTCGCGCCGGGCGTCACCGGCGAGCTGTACCTGGCCGGCGCCGGCGTCTCCCGCGGCTACCTGAACCGCCCCGTGCTGACCGCCGAGCGTTTCGTCGCCGACCCCTACGCCCCGAGCCCCGGCGCCCGCATGTACCGCACCGGCGACCTCGGCCGCTGGAACACCCGCGGCGAACTGGAGTTCGCCGGACGCGCCGACCACCAGGTCAAGATCCGTGGCTTCCGCATCGAACCCGGCGAGATCGAGGCCGCCCTCACCGACCTGCCCGCCGTCGCCCGCGCCGCCGTCGTCGTCCGCGAGGACCGGCCCGGCGACAAACGCCTCGTCGCCTACGCCGTCCCCGCCGGCGAGGGCCTCGACGCGGCCGCCGTGCGCAGCCGGCTGGCCCGCACCCTGCCCGACTTCATGGTGCCCGCCGCGATCGTCGCCCTGGACGCCCTGCCGCTGACCCCCAACGGCAAGCTCGACCGGGCCGCCCTGCCCGCACCGCAGAGCACCACCGCCGTGCAGCGCACCCCGCGTTCACCGCGCGAGGAGATCCTCACCACCCTGTTCGCCGCCGTGCTGAAGCTGCCCCGCGTCGGCATCGACGACAACTTCTTCGACCTCGGCGGCCACTCGCTGCTCGCCACCCGCCTCATCTCCCGCATCCGCACCGTCCTCGGCGCCGAGATCACCCTGCGCGACCTGTTCGAGGCGCCCACCGTCGCCGGACTGGGGGAGCGGCTCGACCAGGCGTCCGGCGCCCGGCCCGCCCTCACCCCCGCCGAGCGCCCCGAGCGGCTCCCGCTGTCGCACGCCCAGCGCCGCCTGTGGTTCCTCGGCCGCCTCGACGGCCCCAACAGCACCTACAACATCCCCCTCGCGCTGCGCCTGTCCGGCACCCTCGACACCGCCGCACTGCGCGCCGCGCTCGCCGACCTCGTGGCCCGCCACGAAACCCTGCGCACCCGCTACCCCAGCCACGACGGCGAGCCCTACCAGCACATCGTCGCCCCCGCGGACGCCACACCCGCCCTCACGGTCGTCCACACCGAGGAGCACCGGCTCGCCGAACAGCTCGCGGAGGCCACCGCACGGCCCTACGACCTCACCACCGAACTGCCGCTGCGTGCCACCTTGTTCCGCCTCGGCGAGGACGAGCACGTCCTGCTCCTGCTGCTGCACCACATCGCCGGCGACGGCTGGTCGCTCGCCCCGCTCACCCGCGACCTCGCCGCCGCCTACGCCGCCCGCCGCGACGGCCACGCCCCCGGCTTCGCACCGCTGCCCGTCCAGTACGCCGACTACACCCTGTGGCAGCGCGGCCTCCTCGGCGACGCCGACGACCCCACCAGCCTCCAGGCCGCCCAGCTCGCCCACTGGCGCCAGGCACTCGAGGGCCGGCCCGCGCACCTGGAACTGCCCTGCGACCACCCCCGGCCCGCCGTCGCCACCCACCGCGGCGCCACCGTGCCCTTCCACATCGACGCCGGCCTCCACGAGAAGCTGACCGCGCTCGCCAAGGCCTGCGACAGCAGCCTGTTCATGGTGCTCCAGGCCGCGTTCGCCGCCCTGCTCACCCGGCACGGCGCCGGCACCGACATCCCCGTCGGCAGCCCCGTCGCCGGCCGCACCGACGACGCCCTCGACGACCTGGTGGGCTTCTTCGTCAACACCCTCGTCCTGCGCACCGACACCTCCGGCGACCCCACCTTCCGCGAACTCGTCGCACGCGTGCGGCAGTTCGACCTCGCCGCCTACACGCACCAGGACATGCCGTTCGAAAAGCTCGTCGAAGAGGTCAACCCCGAGCGCTCCCTGGCCCGCAACCCGCTCTTCCAGGTCGTCCTGGCGCTGCAGTCGATGCCCGCCGCCGACCTGGCCCTGCCGGGCCTGGACGTGGCCGCGGAACCGGTCCGCGTCGGCTTCGCCAAGTTCGACCTCGGCCTCGCCGTCATCGAGGAGCACACCGCCGACGGCACCCGCGCCGGCATCCGCGGCGACTGGGAGTACAGCACCGAACTCTTCGAACGCGGCACGGTCGAAGCCCTCGGCAGCCGCCTGGTGCGCCTGCTGGACGCCGTCGCCGACGACCCGGAGCGCACCATCGGCTCCGTCGACCTGCTGGACGCCACCGAGCGCCACCGTCTCCTCGTCGGCCTCAACACCACCGACGGCCCGCTGCCCGAGGAGCGCACCCTCACCGCCCTGTTCGAACAGCAGGCCGCCGCCACCCCCGACGCCACCGCCCTGGTCATGGGGGACCGCTCCCTGACCTACGCCGAACTCGACGCCCGCGCCAACCGGCTCGCCCGCCACCTCGTGGCCCTCGGCGCCGGCCCGGAGCAGATCGTCGCCCTCCAACTGCCCCGCTCCCTCGACCTGGTCACCGCCGTGCTCGCGGTGTGGAAGTCCGGCGCCGCCTACCTGCCCGTCGACCCGGACTACCCGCCCGAGCGCATCGCCCACATGCGCGCCGACGCCCGCCCCGCCCTCGTCGTCGACGCGATCCCCGACGACACCACGCTGGCGGCATACGCCGACAGCCGCCTCACCGACGCCGACCGCAGCGCGCCGCTGCTGCCCGCCCACCCCGCCTACGTCATCTACACCTCCGGCTCCACCGGGGCGCCCAAGGGCGTCGTCGTCGCCCACCGTTCACTCGCCGCGACCGTCCCCGCCCAGGCCGCCGCCTTCGGACTGGGCACCCACAGCCGCGTCCTGAACTTCGCCTCCATCAGCTTCGACGCCGCCGTGTGGGAGCTGACCTCCGCGCTGTTCACCGGCGCCGGACTCGTCCTGGCCGACGCCGACGACCTGCTGCCCGGCCCGTCGCTGGCCCGCCTCGTCCACGACCGGCACATCACCCTGATCGCCCTGCCGCCCTCCGCCCTGCCCGCCCTGCCCGACGGCGCCCTGCCGCCCGGCACCGACCTCATCGTCGCCGGCGACGCCACCGCCCCCGACCAGGCCGCCCGCTTCGCACCCGGCCGCCGCATGGTCAACGCCTACGGACTGACCGAGACCACCGTGTGCGCCACCATGAGCGAGCCCGCCACCGGCGACGGCGCCCCGCCCATCGGCCGCCCCGTCGCCCACGCCCGCGTCTACGTCCTGGACGAACGGCTGCGCCCCGTACCGCCCGGCGTCACCGGCGAGATGTACGTCTCCGGCGCCGGCGTCGCCCGCGGCTACCTGCACCGCCCCGCCCTGACCGCGCAGCGCTTCGTGCCCGACCCCTACGCCCTGCTGTTCGGCGAGACCGGCACCCGCATGTACCGCACCGGCGACCTGGCACGCCTGGACGCCGACGGCCGGCTGCACTTCGCCGGCCGCGCCGACCAGCAGGTCAAGATCCGCGGCTTCCGCATCGAACCCGGCGAGATCGAGACCGTCCTGACCGCCCACCCGGCCGTCGCCGCCGGCGCCGTGATCGCCCGCGAGGACACCCCGGGCGACAAACAGCTCGTCGCCTACCTGACGCGCGACACCACCCACCACGCCGCACCGGACCAGGACCTGGGCACCGGCCAGGTCGACCGCTGGCAGCAGACCTACGACTCCCTCTACGAGGCCGAACCCGGCCGCGCCTTCGGCGAGGACTTCTCCGGCTGGAACAGCAGCTACACCGCCGAGGAGATCCCCCTGGAGGAGATGCGCGAGTGGCGCGCCGCCACCGTCGACCGCGTCCTCGCCCTGCGCCCCCGGCGGGTCCTGGAGATCGGCTGCGGCACCGGCCTGATCCTGTCCCAGGTCGCCCCCCACACCGAGGAGTACCGGGGCACCGACCTCTCCCGCAGCGTCGTCGCCAGGCTGGCGGCCCACCTCGCCGGCCGCCCCGACCTGGCGGACAAGGTCACCGTGGACGCCCGCGCCGCACACGAGACGGACGACCTGCCCAAGGGCCGCTTCGACACGATCGTCCTCAACTCCGTCGCCCAGTACTTCCCCGACGCCCGCTACCTCGCCGGCATCCTCCACCGGGCCGCCGAACTGCTGGCCCCCGGCGGCACGATCTTCCTCGGCGACATCCGCAACCTGCGCACCCTGCACGCCTTCCGCACCGCCGTCGAACTGCGCCGCGCCGGCCCCTTCGCCGACCCCGCGGCCGTACGCCGCGCCGTCGAACAGTCACTGGCCACGGAGAAGGAACTCCTGCTCGACCCCGACTTCTTCACCGACCTCGTCGACCGCGACCCGCACCTGACCCGCGCCGACATCACCCTGCGCACGGCCGCCCACCACAACGAGATGAGCCGCCACCGCTACGACGTCACCCTCCACCGCGGCGGCGACAGCCCCGCCCCGGCGGAGACCGTCCTGCGCTGGGGCACCGACCTCGACACCGCCGGCGAACTCGCCCGCGTCCTCTCCGGCCCGCGCCCCGTGCGCGTCACCGGCATCCCCAACGCCCGCCTCACCGGCGAGACACGCGCCGCACAAGCCCTCGAACGCGGATCGGCGGCCGACGCCTGCGCCCGGCTCGAAGCCCCCGCCCCGGCCGGCGCACTCGACCCCCACGACGTGTACGCGCTGGGCGCCGTGTGCACCTGGGGCCACGACGACGACACCTTCGACGCCTACGCGGGCGACGGCACCGCCTACCGCCCCCGCACCGGCCGGCAGGGACCGCTCGCCAACGACCCGGCCCGCGCCGAGCAGGACGCCGCCCTCGTCGGCGAACTGCGCGACCTCGTCGCCCAGCGGCTGCCCGCCCACATGGCGCCCGCCGCCTACGTCCTGCTCGACCGCCTGCCGCTGAGCGCCAACGGCAAACTCGACCGCGACGCGCTGCCCGCCCCCGACCGCGGCGAGGACGCGGCCGGCCAGGCACCCCGCACCCGCCGCGAGGAGATCCTGTCCACCCTGTTCGCCGAGGTGCTGGGCCTGCCGGCGGTCGGCATCGACCGCAGCTTCTTCGACCTGGGCGGCCACTCGTTGCTCGCGACCCGGCTGCTCAGCCGCATCCGCAGCGTCCTGGGCGCCGAACTCGCCGTCCGCGACCTGTTCCAGGCGCCGACGGTCGCCGCGCTCGCCGAACGCGTCGACGGCGCCCAGGAGGCCCGCCCGCCGCTCACCGCCCGCACCCGCCCCGCCGAGGTGCCGCTGTCCTTCGCCCAGTACCGGCTGTGGTTCCTGCACCGCATGGAGGGCCCCGGCCCCACCTACAACATCCCCATGAGCCTGCGTTTGACCGGGACCCTGGACACCGCCGCGCTGCGCGCCGCGCTCGCCGACGTCACCGCCCGCCACGAAGCGCTGCGCACCGTCTACCCCGAGAGCGGCGGCGTCCCGCGCCAGCACGTCCTGCACGACGTCCGCCCCCACTTCGAGACCGCCGACACCACCGCACAGACCCTCGAGGCCGACCTCACGCGCGCCGCCCGCCGCGGCTTCGACCTCGCCCGCGAACTGCCGCTGCGCGCCACCTTGTTCCGCCTCGCCGAGGACGAGCACGTCCTGCTGCTGCTGATGCACCACATCGCCGGCGACGGCTGGTCCTGGCCGCCGCTCGCCCGCGACCTCGGCGACGCGTACGCCGCCCGCCTCGCCGGACGCGCCCCCGACCTGCCGCCGCTGCCCGTCCAGTACGCCGACTACGCGCTGTGGCAGCGCGACCTCCTCGGCGACGAGGACGACCCCACCAGCCGCCACGCCCGCCAGCTGGCGTACTGGGCCGGCGCCCTCGACGACCTCCCCGAGGAACTGCAACTGCCCTGCGACCGGCCCCGGCCCGCCGTCGCCACCCACCGCGGCGACACCGTGCCGTTCGCCGTCGACCCCGACCTGCACCAGCGGCTCAACGCCCTCGCCACCGAAGGCCGGGCCAGCCTCTTCATGGTGCTCCAGGCCGCGTTCGCCGCCCTGCTCACCCGGCACGGCGCCGGCACCGACATCCCCCTCGGCAGCCCCATCGCCGGCCGCACCGACGACGCCCTCGAGGACCTGGTGGGCTTCTTCGTCAACACCCTCGTGCTGCGCACCGACACCTCCGGCGACCCCACCTTCCGCGAACTCCTCCAGCGCGTACGCGAGTCGGACCTCGCCGCCTACGCCCACCAGGACGTCCCCTTCGAGAAGCTCGTCGAGAAGCTGCGACCCGAACGCTCCCTGTCCCGCCACCCCCTCTTCCAGGTGATGCTCGCCTTCCAGAACAGCGGCGAGGCCCGCCTCGCCCTGCCCGGCCTCGACGCCCGGGCCCTGCCCGTCGGCGTCGGCGTCGCCAAGTTCGACCTGCACCTGAGCATGGTCGAACTCCGCACCGGCGACGGCCGGCCCGGCGGCATCCAGGCCGCCCTGGAATACGCCACCGACCTGTTCGACCGCACCACCGCCCAGGCGCTCGTCGACCGGCTGCTGCGGCTCCTGGCCGCCGTCGCCGACGACCCCGGGCTCACCGTCGGCCGCGTCGAACTCCTCGACCCCGCCGAACGCCACCGCGTCCTTCAGGACTGGAACACCACACCCGGCGGCGACGGCGCCGCCCGCACACCCGTCACCGAACTCCTCGAACGCCAGGCGGCGCGCACCCCCGACGCCGTGGCCCTGGTCCACGACGACGGCCGGCTGACCTACGCCGAACTCCACGCCCGCGCCAACCGGCTCGCCCGCCACCTGATCACCCTCGGCGCCGGACCCGAACAGATCGTCGCCCTGCGCATGCCGCGCTCCCTCGACCTGTACGTCGCACTGCTCGCCGTCCTCAAGACCGGCGCCGCCTACCTGCCCGTCGACATCTCCTACCCGGCCGAACGCATCGCGTTCATGATCGAGGACGCCCGCCCGGTGACCGTCCTCGACCGCCTGCCCGACGACCTGGGCGCCTACCGGGACACCGACCTCACCGACGCCGACCGCACGGCGCCGCTACGGCCCGAACACCCGGCGTACGTCATCCACACCTCCGGCTCCACCGGCACCCCCAAGGCCGTCGTCATGCCCCACGCCGGCCTGGCCAACCTGCTGACCTGGCACGCCCGCCGCTTCCCCGGCGGCACCGGGGTGCGCACCGCCCAGTTCACCGCCATCGGCTTCGACTTCTCGGTGCAGGAGATCCTCTCCCCGCTCGTCATGGGCAAGACCCTCGCCGTGCCCTCGGAAGAGGTCCGCCACAGCGCCGAACTGCTGGCCGGCTGGCTCGAGACACAGCAGATCAACGAACTGTTCGCGCCGAACCTCGTCATCGAGGCCCTCGCGGAGGCCGCCGCGGAGGCCGGCCGCACCCTGCCGGACCTCACCGACATCCTCCAGGGCGGCGAGGCCCTCGCCCCCACCGAACGGGTACGCGCCTTCACGGCCGCCGTACCCGGCCGGCGCCTGCACAACGTGTACGGCCCCGCGGAGACCCACGCCGTCACCACCCACACCCTGGCCGCTGATCCCGCCCACTGGCCCCCCTCCGCACCCATCGGCCGGCCCGTCGACCACGACCGCGTGTACGTCCTGGACAGCGCACTGCGCCCCGTCCCGCCGGGCGTCACCGGCGAGCTGTACCTGGCCGGCGCCGGCGTCGCCCGCGGCTACCTGCACCGCCCGCGCACCACCGCCGAGCGTTTCGTCGCCGACCCCTACGCCCCACGGCCCGGCGCCCGCATGTACCGCACCGGCGACCTCGGCCGCTGGAACACCCGCGGCGAGCTGGAGTTCGCCGGCCGCGCCGACCACCAGGTCAAGATCCGCGGCTTCCGCGTGGAGCCCGGCGAGGTCGAGGCCGCCCTCACCGCCCACCCCCGCATCACCCAGGCAGCGGTCCTCGCGCACGGCGACCGCCTCGTCGCCTACGTCGTCACCACCGCGGACCGCGACCTGACCGGCGTACGCGAGCACCTGGCCGCCCGCCTGCCCGACTTCATGGTCCCCACCGCCTACGTCCGCCTCGAGGCGCTGCCGCTCACCGTGAACGGCAAACTCGACCGGGCCGCCCTGCCCGCACCGGACGCCCCCGCCGCCGGGCGCGCCCCGCGCACCGTGCGCGAGGAGATCCTGTGCGGCCTGTTCGCCGAGGTGCTGGGCACCGAACGGGCCGGCATCGACGACAACTTCTTCGACCTCGGCGGCCACTCGCTGCTCGCCACCCGCCTCATCTCCCGCATCCGCACCGCCCTGGGCGCCGAGATCACCCTGCGCGACCTGTTCGAGGCGCCCACCGTCGCCGGACTGGGGGAGCGGCTCGACCAGGCGTCCGGCGCCCGGCCCGCCCTCACCCCCGCCGAGCGCCCCGAGCGGCTCCCGCTGTCCTACGCCCAGCGCCGCCTGTGGTTCCTCGGCCGCCTCACCGGCGGCGACCCCGGCTACAACATGCCCGTCGGACTGCGCCTGTCCGGCACCCTCGACACCGCCGCGCTGACCGCCGCCCTCGCCGACCTCGTGGCCCGCCACGAAACCCTGCGCACCGTCTTCCCCGAAGGCGACGACGGCAGCCCCCACCAGCTCGTCCTCGACCCCGGCGCCGCCCGCCCCGCACTGCACCCGCGGGACACCACGCAGGACGACCTCGCCACGGAACTGGCCGCCGCCGCCCGCCACTGCTTCGACCTCACCACCGAACTGCCGCTGCGCGCCACCCTGTTCCGCCTCGCCGAGGACGAGCACGTTCTGCTCCTGCTGCTGCACCACATCGCCGGCGACGGCTGGTCGCTCGCCCCCCTCGCCCGCGACCTGGTCACCGCCTACGCCGCCCGCCGCGACGGCCACGCCCCCGACTTCGCGCCGCTGCCCGTCCAGTACGCCGACTACACCCTGTGGCAGCACGCCCTCCTCGGCGACGAGAACGACCCCGACAGCACCATCAGCCGGCAGAGCGCCCACTGGAAGGACGCCCTCGCCGGCCTGCCCGAGGAGATCCAGCTCCCCGCCGACCGGCCCCGGCCCGCCACCCCCGCACACCGCGGCGAAGCCGTCTTCCGCACCCTCGACGCCGACCTGCACCGCGAGCTGCTGCACCTCGCCCGCACCGGCGGCGCCAGCCTCTTCATGGTCCTCCAGGCCGCGGTCGCCGCCGTACTCACCCGGCACGGCGCCGGCACCGACATCCCCCTCGGCAGCCCCATCGCCGGCCGCACCGACGACGCCCTCGACGACCTGGTGGGCTTCTTCGTCAACACCCTCGTCCTGCGCACCGACACCTCCGGCAACCCCACCTTCCGCGAACTCCTCGACCGGGTACGCGAGTTCGACCTCGCCGCCTACGCCCACCAGGACGTGCCCTTCGAAAAGCTCGTCGAGGACGCGGCACCCGGCCGCTCCCTGTCCCGCCACCCCCTCTTCCAGGTCCTGCTGGCCCTGCAGAACACCCCCGAAGCCGTCCTCGAACTGCCCGGACTCACCGCCCGCCCCGAGGTCGTCACCCTCGGCGCCGCCAAGTTCGACCTCACCTTCAACCTGGCGGAACGGCACGGCCCCGACGGCGAACCCCACGGCATCGACGCCGTCCTCGAATACAGCACCGACCTGTTCGACCGCACCACCGCCGAAGCACTCACCGACCGGCTCATCACCTTCCTGCGCGCCGTCGCCGCCGACCCCGGCCGCACCGTCGCCGACGTGCCGATCCTCGACGCCGACGACCACGCCCGCGTCCTCACCGGCTGGAACGACACCGACCACCCCCGCGGCCGGCGCACCGCCGACGCCTGCCTGCCCCGCCGCATCGCCGAACAGGCCGCCCGCACCCCGCACGCGGTCGCCGTCACCGAAGCCGGCGGCACCCTGATCACCTACAGCGAACTCGACGCCCGCGCCAACCGCCTGGCCCGCCACCTGATCCGCCGCGGCGTCACCGCGGAGACCCGCGTCGCCGTCCTCGCCGAACGCTCCGCCCAGCTCGTCGTCACCACCCTCGCGATCCTCAAGGCCGGCGGCGTGTACGTGCCCCTGCACACCGGCTATCCCGTCGACCGGATGCGGCACGTCCTCGCCGACACCGAAGCGGCCCTGCTGCTCACCGACACCCACCACGCCGCCACCGCGGCCCGCCTGGACACCCCCGCCCTCACCGTCGACGAGGACACCACGGCCGGCGAGCAGGACACCACCGCCCCGGACGTCACCGTGCGGCCCGACCAGCTCGCCTACATCATGTTCACCTCCGGCTCGACCGGCACCCCCAAGGGCATCGGCATCACCCACCGCGACGCCATCGCCCTGGCCGCCGACCGCTGCTGGGACCTGGACACCGGCTCCCGCGTCCTGATGCACTCCCCGTACGCCTTCGACATCTCCACCTTCGAACTGTTCGCCCCGCTGCTGGCCGGCGGGCGGATCGTCGTCGCACCCCGCGGCGACATCGACGCGGCCGTCCTGCAGCGCACCCTCGCCGCCCACGGCGTCACCTCGCTGCTGCTGACCGCCGGCCTGCTCGGCGTGATCGCCGACGAGGCACCGGAGGTCTTCACCGGCGTCAAGGACGTGTGGACCGGCGGCGACGTCGTCTCTCCCACCGCCGTGCGCCGCGTCCTCGAAGCCTGCCCCGGCACCGTCGTCAAGACCCTCTACGGGCCGACCGAGACCACCCTGGGCTGCACCTGGCTGCCGTTCACCGACCCCCGCCGCATCCCGCCCGCCGTCCCCATCGGCCGGCCGCTGGACAACACCCGCGCCTACGTCCTCGACGAACGGCTGCGGCCCGTACCGCCCGGCGTCACCGGCGAGCTGTACATCGCCGGCGCCGGCCTCGCCCGCGGCTACTGGGACCAGAGCGCCCGCACCGCGGAACGCTTCACCGCCGACCCGCACGCCCACCTGTTCGGCGACACGGGCGGCCGCATGTACCGCACCGGCGACCTGGCCCGCCGCGACGCCGACGGCGTCCTCCACTTCTGCGGCCGCGCCGACCAGCAGGTCAAGATCCGCGGCTTCCGCATCGAACCCGGCGAGATCGAGACCGCGCTCGCCGCCCACCCCGACGTCACCCGCGCCGCCGTCGTCGCCCGCCCCGGCCGGGCCGGCGACAAGGTCCTCGTCGCCTACCTCGTCACCGCCCCCGACGCGGGCGACACCACCGCCGAACAACTGCGCGCCGGCCTCGAGACCCAACTGCCCGACTACATGGTCCCCGCCGCGTTCGTCGCGCTGCCCGCCCTGCCCGTCACGCCCAACGGCAAACTCGACCGCGACGCACTGCCCGAACCCGACTGGGGCGGCGGCGCCGGACGCCCGCCCCGCGGCCCCCGCGAGGAAATCCTGTGCGGCCTGTTCGCCGAGGTCCTCGGCGCCCCCCGGGTCGGCACCGACGACAACTTCTTCGAACTCGGCGGCCACTCCATGCTCGCCACCCGCCTCGTCGGCCGCGTCAAGACCGTCCTCGGCGCCGACATCGGCGTACGCACCCTCTTCGAGGCGCCGACCGTCGCCGCCCTCGCCGCCCGCATCGACGGCGCCGACACGGGCCACGACCCCTTCGGCGTGGTGCTGCCGCTGCGCACCGGCGGCAGCCGCGCCCCCCTGTTCTGCGTCCACCCCGCCGGCGGCTTCGGCTGGGTCTACTCCGCACTGCTGCGCCACACCGACCGCGAACAGCCCCTGTACGCCCTCCAGGCACGCGGCCTGGCCCGCCCCGAGCCACTGCCCGACGACATCGACGCCATGGCCCGCGACTACGCAGAACAGATCCGCAAAACGGTGCCCGAGGGCCCCTACGAGATCCTCGGCTGGTCCTTCGGCGGCCTCGTCGCCCACGCCGTCGCCGCCCGCCTGCAGGCCGAGGGCGCCGAAGTGAGCCTGCTGGCCGTCCTCGACGGCTACCCCGACGCCTACGACGGCACCGAGCACGAGGTCGGCGAGGAACAGGTCCTGGCGATCCTCCTCAACGCCGCCGGCGTCGACCGGGCCCAGGCCTTCGGCGACGCCCCCCTCCAACGGGCCGCCGTGCTCGAGAAGCTGCGCGACAGCGGCAGCGCCCTGGGCAACCTCGACGACGACGCGGTCGGCCGCATGGTCACCGTCTTCCTCAACAACACGCGCCTCATCCAGAACTTCCGGCCCCGGCGGTTCACCGGCGACATGGTGTTCTTCGCCGCCGCCGCCGGCCACCACGACCCGGCGCTCACCCCCGGCAACTGGCGCCCCTACGTCACCGGGCGGATCGAGGAGCACCACCTGGACACCGACCATGCCGGCCTGGCCCGGCCCGAGGCCCTGGGCGCCGTCGCCCGGACGCTGGCACAGCGCGACACGCCGCAGGCCGGCCACTGA	MTRSGLADVLPLSPLQEGLLFQVTYGAETHGPDVYTVQMVFELRGPLDEDGLRAAAAALLRRHPNLRAGFWQQGVERPVQFVPNEVPLPWHTRDFTALGESDRERAVEAYVTADRAERFDPGAPPLIRFALLGLAADHHKLVLTTHHLLLDGWSMPLLVRELFTLYGQRGDDAGMPPVTPYRAYLAHLAGRDDDAARAAWRTALADLEEPSLVAGAGAGRGAADGSALPGQIWHEIDAATTAGLTALARSCNITLNTLVQSAWALLLGRQLGRDDVVFGATVAHRPPEIPGIESTIGMFINTLPVRVRVRPAETLGDLLGRVQREQAALIEHRHLSLTDIRSTTGTGELFDTVVVFENYPLDPAVLRAEARGLRLAGFEVSDATHYPLSLLAIPGESLRFRLDHRGDVLDEAGARLLLERLDTLLTDIAEHGADLPVGRLDLLSAAERHQVLEEFNDTGLPAEDATLAALFEAQAARTPDTTALLVGGRSLTYAELNARANRLARHLVTLGAGPEQIVAVKLERSLDLYVALLAVLKTGAAYLPVDTAYPAERIAFMMDDARPAVVLTGEDTGQDLSGYDDTDLTDADRTAPLLPAHPAYVIYTSGSTGTPKAVVMPGAALVNLLAWHRREIPGEAGAPVAQFTTIGFDVAAQEILATWLHGKTLAVPSQEVRRSAEQLAAWLDEQHVSELYAPNLVIEALAEAAAEAGRTLPALRHIAQAGEALTLTRTVREFAAAVPGRQLHNHYGPAETHVMTGTALPEDPAAWSEHAPLGRPVSGARVYVLDSALRPVAPGVTGELYLAGAGVSRGYLNRPVLTAERFVADPYAPSPGARMYRTGDLGRWNTRGELEFAGRADHQVKIRGFRIEPGEIEAALTDLPAVARAAVVVREDRPGDKRLVAYAVPAGEGLDAAAVRSRLARTLPDFMVPAAIVALDALPLTPNGKLDRAALPAPQSTTAVQRTPRSPREEILTTLFAAVLKLPRVGIDDNFFDLGGHSLLATRLISRIRTVLGAEITLRDLFEAPTVAGLGERLDQASGARPALTPAERPERLPLSHAQRRLWFLGRLDGPNSTYNIPLALRLSGTLDTAALRAALADLVARHETLRTRYPSHDGEPYQHIVAPADATPALTVVHTEEHRLAEQLAEATARPYDLTTELPLRATLFRLGEDEHVLLLLLHHIAGDGWSLAPLTRDLAAAYAARRDGHAPGFAPLPVQYADYTLWQRGLLGDADDPTSLQAAQLAHWRQALEGRPAHLELPCDHPRPAVATHRGATVPFHIDAGLHEKLTALAKACDSSLFMVLQAAFAALLTRHGAGTDIPVGSPVAGRTDDALDDLVGFFVNTLVLRTDTSGDPTFRELVARVRQFDLAAYTHQDMPFEKLVEEVNPERSLARNPLFQVVLALQSMPAADLALPGLDVAAEPVRVGFAKFDLGLAVIEEHTADGTRAGIRGDWEYSTELFERGTVEALGSRLVRLLDAVADDPERTIGSVDLLDATERHRLLVGLNTTDGPLPEERTLTALFEQQAAATPDATALVMGDRSLTYAELDARANRLARHLVALGAGPEQIVALQLPRSLDLVTAVLAVWKSGAAYLPVDPDYPPERIAHMRADARPALVVDAIPDDTTLAAYADSRLTDADRSAPLLPAHPAYVIYTSGSTGAPKGVVVAHRSLAATVPAQAAAFGLGTHSRVLNFASISFDAAVWELTSALFTGAGLVLADADDLLPGPSLARLVHDRHITLIALPPSALPALPDGALPPGTDLIVAGDATAPDQAARFAPGRRMVNAYGLTETTVCATMSEPATGDGAPPIGRPVAHARVYVLDERLRPVPPGVTGEMYVSGAGVARGYLHRPALTAQRFVPDPYALLFGETGTRMYRTGDLARLDADGRLHFAGRADQQVKIRGFRIEPGEIETVLTAHPAVAAGAVIAREDTPGDKQLVAYLTRDTTHHAAPDQDLGTGQVDRWQQTYDSLYEAEPGRAFGEDFSGWNSSYTAEEIPLEEMREWRAATVDRVLALRPRRVLEIGCGTGLILSQVAPHTEEYRGTDLSRSVVARLAAHLAGRPDLADKVTVDARAAHETDDLPKGRFDTIVLNSVAQYFPDARYLAGILHRAAELLAPGGTIFLGDIRNLRTLHAFRTAVELRRAGPFADPAAVRRAVEQSLATEKELLLDPDFFTDLVDRDPHLTRADITLRTAAHHNEMSRHRYDVTLHRGGDSPAPAETVLRWGTDLDTAGELARVLSGPRPVRVTGIPNARLTGETRAAQALERGSAADACARLEAPAPAGALDPHDVYALGAVCTWGHDDDTFDAYAGDGTAYRPRTGRQGPLANDPARAEQDAALVGELRDLVAQRLPAHMAPAAYVLLDRLPLSANGKLDRDALPAPDRGEDAAGQAPRTRREEILSTLFAEVLGLPAVGIDRSFFDLGGHSLLATRLLSRIRSVLGAELAVRDLFQAPTVAALAERVDGAQEARPPLTARTRPAEVPLSFAQYRLWFLHRMEGPGPTYNIPMSLRLTGTLDTAALRAALADVTARHEALRTVYPESGGVPRQHVLHDVRPHFETADTTAQTLEADLTRAARRGFDLARELPLRATLFRLAEDEHVLLLLMHHIAGDGWSWPPLARDLGDAYAARLAGRAPDLPPLPVQYADYALWQRDLLGDEDDPTSRHARQLAYWAGALDDLPEELQLPCDRPRPAVATHRGDTVPFAVDPDLHQRLNALATEGRASLFMVLQAAFAALLTRHGAGTDIPLGSPIAGRTDDALEDLVGFFVNTLVLRTDTSGDPTFRELLQRVRESDLAAYAHQDVPFEKLVEKLRPERSLSRHPLFQVMLAFQNSGEARLALPGLDARALPVGVGVAKFDLHLSMVELRTGDGRPGGIQAALEYATDLFDRTTAQALVDRLLRLLAAVADDPGLTVGRVELLDPAERHRVLQDWNTTPGGDGAARTPVTELLERQAARTPDAVALVHDDGRLTYAELHARANRLARHLITLGAGPEQIVALRMPRSLDLYVALLAVLKTGAAYLPVDISYPAERIAFMIEDARPVTVLDRLPDDLGAYRDTDLTDADRTAPLRPEHPAYVIHTSGSTGTPKAVVMPHAGLANLLTWHARRFPGGTGVRTAQFTAIGFDFSVQEILSPLVMGKTLAVPSEEVRHSAELLAGWLETQQINELFAPNLVIEALAEAAAEAGRTLPDLTDILQGGEALAPTERVRAFTAAVPGRRLHNVYGPAETHAVTTHTLAADPAHWPPSAPIGRPVDHDRVYVLDSALRPVPPGVTGELYLAGAGVARGYLHRPRTTAERFVADPYAPRPGARMYRTGDLGRWNTRGELEFAGRADHQVKIRGFRVEPGEVEAALTAHPRITQAAVLAHGDRLVAYVVTTADRDLTGVREHLAARLPDFMVPTAYVRLEALPLTVNGKLDRAALPAPDAPAAGRAPRTVREEILCGLFAEVLGTERAGIDDNFFDLGGHSLLATRLISRIRTALGAEITLRDLFEAPTVAGLGERLDQASGARPALTPAERPERLPLSYAQRRLWFLGRLTGGDPGYNMPVGLRLSGTLDTAALTAALADLVARHETLRTVFPEGDDGSPHQLVLDPGAARPALHPRDTTQDDLATELAAAARHCFDLTTELPLRATLFRLAEDEHVLLLLLHHIAGDGWSLAPLARDLVTAYAARRDGHAPDFAPLPVQYADYTLWQHALLGDENDPDSTISRQSAHWKDALAGLPEEIQLPADRPRPATPAHRGEAVFRTLDADLHRELLHLARTGGASLFMVLQAAVAAVLTRHGAGTDIPLGSPIAGRTDDALDDLVGFFVNTLVLRTDTSGNPTFRELLDRVREFDLAAYAHQDVPFEKLVEDAAPGRSLSRHPLFQVLLALQNTPEAVLELPGLTARPEVVTLGAAKFDLTFNLAERHGPDGEPHGIDAVLEYSTDLFDRTTAEALTDRLITFLRAVAADPGRTVADVPILDADDHARVLTGWNDTDHPRGRRTADACLPRRIAEQAARTPHAVAVTEAGGTLITYSELDARANRLARHLIRRGVTAETRVAVLAERSAQLVVTTLAILKAGGVYVPLHTGYPVDRMRHVLADTEAALLLTDTHHAATAARLDTPALTVDEDTTAGEQDTTAPDVTVRPDQLAYIMFTSGSTGTPKGIGITHRDAIALAADRCWDLDTGSRVLMHSPYAFDISTFELFAPLLAGGRIVVAPRGDIDAAVLQRTLAAHGVTSLLLTAGLLGVIADEAPEVFTGVKDVWTGGDVVSPTAVRRVLEACPGTVVKTLYGPTETTLGCTWLPFTDPRRIPPAVPIGRPLDNTRAYVLDERLRPVPPGVTGELYIAGAGLARGYWDQSARTAERFTADPHAHLFGDTGGRMYRTGDLARRDADGVLHFCGRADQQVKIRGFRIEPGEIETALAAHPDVTRAAVVARPGRAGDKVLVAYLVTAPDAGDTTAEQLRAGLETQLPDYMVPAAFVALPALPVTPNGKLDRDALPEPDWGGGAGRPPRGPREEILCGLFAEVLGAPRVGTDDNFFELGGHSMLATRLVGRVKTVLGADIGVRTLFEAPTVAALAARIDGADTGHDPFGVVLPLRTGGSRAPLFCVHPAGGFGWVYSALLRHTDREQPLYALQARGLARPEPLPDDIDAMARDYAEQIRKTVPEGPYEILGWSFGGLVAHAVAARLQAEGAEVSLLAVLDGYPDAYDGTEHEVGEEQVLAILLNAAGVDRAQAFGDAPLQRAAVLEKLRDSGSALGNLDDDAVGRMVTVFLNNTRLIQNFRPRRFTGDMVFFAAAAGHHDPALTPGNWRPYVTGRIEEHHLDTDHAGLARPEALGAVARTLAQRDTPQAGH	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	871.94	gnl|BL_ORD_ID|4935|hsp_num:0	5928			168	1629	colistin A; colistin B
BGC0000952.1|Pristinamycin_13 # 33206 # 40981 # -1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.755	BGC0000952.1|Pristinamycin_13 	33206	40981	-	Loose	1000	128.257	almE	30.4	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGCTCGTTCCCGACGACGCGCGTCTGCCGCTGACGGCGGCCCAGCTCGGCATCTGGTTCGCGCAGGCGCGGGACCCGCACAGTCCCGTCTTCAACACCGGCGAATACGTCGAACTCACCGGCGGCCTCGACGCCGACCGCTTCGAGGCGGCGCTGCGCGCCACCGTCGCCCGCACCGACGCCCTGCGGCTGCGTTTCCACACCGACGCCGAGGGGACCGTCACCCAGTCCGTCGCCGACGACGTCCCCTTCACCCTGCACCGCGTCGACGTCAGCGCCGAGGACGACCCCGCGGCCGCCGCGGACGCCTGGATGCGCGACGTCATCGCCCGGCCCCTCGACGTGACCTGCGGCCGGCCCCTGTTCACCCAGGCGCTGTTCACCCTCGGCCCCGGCCGCCACCGCTGGTTCCAGCACGTGCACCACCTGCTCCTCGACGGGTACGGCTTCCGCCTCGTCGCCGAACGCGTGGCCGCCGCCTACCGCGCCGGAGCCGAAGCAGGCGACGCCGAAGCCGGTGACACCGAGCCCGGCATACGGGACCTGCTCGCCGCCGAGGCCGACTGGCGCGCCTCCGACGCCTACGCCCAGGACCGCGCCCACTGGCTCGCCACCCCCCGCCACACGCCCGTCACCCTCGCCGGCACCACCGCCCCGGGAGCGCCGGGCGCGCTGCGCCGCACCGCGTCCGCCGGACCCGAGGTGCTCGCCGGACTCGACGCCGTGGCCCGCGCCGCGGAGACCGGCCGGCAGGTCGCCTTCCCGGCCGCCGTCGCCGCCTACGTCCAGTGGCTGACGGGGGAGCGGACCGTCACCCTCGGCATGCCGGTCACCGCCCGCCGCACCTCCGCCGCCCGCCGCGCGCCCGGCACCGTCGCCAACGTGCCCGCACTGCACGTCGAACCGCGCCCCGCCGCCCCGCTCGCCGAACTGGTCGCCTCCGTGCGCGACGCCCTCGAGCCGCTGCTGCGCCACCAGCGCTACCCCTACGAGGAGGCGCGCCGCGAGCTCGGCGCGGTCGGCGAACGGGCCTACGGCCCCGTCGTCAACGTCATGCCCTACGGGCGCGCCCTGGACTTCGGCGGCCCGGCGGCGTCCGTGCACCCGGTGTCCACCGGCCCCGTGGAGGACCTGAAGTTCTCCGTGTACGAGGAGCCCGACGGCTCCGGCGCGCGGATCGACCTCGAGGCCAACGCGGCCGTGTACGGCGAGAGCGAGACCGACGCCCATCTGGCGCGCTTCGTCCGTTTCCTGGGCGCCTTCGCCGAGGCGGGCCCGGACACGCCGCTCGGCCGGATCCACGCGGCGGCCCCCGCCGCCCCCGCCGCCGCGGCGCCCACCACCGGCGGCCCCGCGCTGCACACCCTGTTCGCCGCCCGCGCCGCGGCCACCCCCCACGCGGTGGCCGTCAGCCACGACGGAGACCACCTCACCTACGCGCAGCTCGACGCCCGCGCCAACCGCCTCGCCCACCGGCTCGTCGAGCAGGGCGCAGGCCCCGAACGGCTCGTCGCCCTCACCCTGCCGCGCTCCCTCGACCTGGTCGTCGCCCTGCTCGCGGTCCTCAAATCCGGCGCCGCCTACCTGCCGCTCGACCCCGACTACCCGGCCGACCGGCTGGCCTGGATGCTCGAGGACGCGGCCCCCGTCCTCGTCCTCGACCCGCAGGCGATGACCGAGGACCTCGCCGGCTACCCGGACACCGCCCCGCGTACCGCCGTGGACGGCGCCCACCCCGCCTACGTCATCTACACCTCCGGCTCCACCGGCCGCCCCAAGGGCGTCGTGATCCCGCACAGCAACGTGGTGCGCCTGTTCACCTCCACCGACCACTGGTTCGGCTTCGGCCCCGACGACGTGTGGACCCTCTTCCACTCCTACGCCTTCGACTTCTCCGTCTGGGAGATCTGGGGCGCCCTGCTGCACGGCGGCCGGCTCGTCGTCGTCCCGTACCACGTCAGCCGCTCGCCCGGGGACTTCCTCGACCTGCTGGCCCGCGAGAAGGTCACCGTCCTCAACCAGACACCGACCGCCTTCCACCAGCTCGACGCCGCCGACCGGGCCCGTACCGCCGCCCCCGAACTGGCCCTCAGGTACGTCGTGTTCGGCGGCGAGGCTCTCGACGTGGCCCGTCTCGCCGACTGGTACGCCCGCCGCGGCACGGCCGCCCGCCTGGTCAACATGTACGGCATCACCGAGACCACCGTGCACGTCACGCACGCCCCCCTCGGCCCCGGCCACGCCGTCCCCGGCACCCCCTCCCTGCTCGGCGGCCCCATCCCCGACCTCACCCCCCGCGTCCTGGACGCCGCCCTGCGGCCCGTGCCGCCCGGCTTCACCGGCGAGCTGTACGTCGCCGGGGCGGGCCTGGCCCGCGGCTACCTGAACCGGCCCGCGCTGACCGCCCAGCGGTTCCCCGCCGACCCCTACGGGGCGCCCGGCACCCGCATGTATCGCACCGGCGACCTGGTGCGCCACCTCGACGACGGCACGTACGCCTACCTGGGCCGCGGCGACGACCAGGTCAAGATCCGCGGCTTCCGGATCGAACTCGGCGAGATCGAGAACGTCCTCGCCACCCACCCCGGCGTCGCCCAGGCCGCCGCCGTCGTCCGCGAGGACCGGCACGGCGACCTGCGGCTGGCCGCCTACGCCGTCCCCACCCCCGGGACCGAACCCGACGTGGCCGGCTGGCGCGCCCTGCTGGCCGGGCAACTGCCCGCGCACAGCCTGCCCGCCTCCTTCACGCTCCTCGCCGCGCTGCCGCTGACCGCCAACGGCAAACTCGACCGGGCGGCCCTGCCCGCCCCGCAGGCACCCGCCCCCGAGACCGCCGACGAGCCCGCCCCGGCCGCCGACCCCGGCGAGGCGGCCCTGCGCCGCATCTTCGCCGACACCCTCGGCACCCCGCGGGTGGGCGCGGACAGCGACTTCTTCACCCTCGGCGGCCACTCGCTGCTCGCCGGACGCCTCATCGCCGCCGTACGCGACACCCTCGGCGCCGAGATCACCATCCAGGACCTCTTCGAGGCCCCCACCCCCGCCGGCCTCGCCGCCCGGGTGCGCACCGCCGCCACCGGCCGCCCGCCGCTCGTGCCCAGGGACCACGGCGACGGCCCCCGCCCCACCTCCTACGCCCAGCACCGCATGTGGGTGCTGCGCGAGGTCGAGGGCGCCGCACCCACCTACAACATGCCGCTCGCGCTGCGCCTTTCCGGCACCTTGAACCGCACCGCGCTGCGCGCCGCCCTCTACGACGTCGTCGTCCGGCACGAGAGCCTGCGCACCGTCTACCCGCGCGGCGAGCACGGCGTCACCCCCCGGCTGCTGCCGCCCGAGCAGGCCCGCCCCTGGGTCATCGAGTCCCGCGTCGACGACGAACAGCTCCCCGCCGCCCTGACCGCCGCCGCCCGCGAACCGTTCAACCTCGACTGCCAACTCCCCATACGGGCCCACCTGTTCACCCTGCCCGGCGGGGACAGCGTGCTGCTGCTGCTGATGCACCACGTCGCCGGCGACGGCTGGTCGCTGCGCCCCCTGCTCGGCGACCTGTCCACCGCCTACGCCGCCCGGCTCGCCGCCCGCGCCCCCGACTTCCCGCCGCTGCCCGTCAGCTACGCCGACTTCGCCGTGTGGCAGCGCGAACTCCTCGGCGACGAGCACGACCCCGACAGCCTCGCCGCCCGCCAGCTCGCCCACTGGGAGAGCACCCTGGCCGGCCTGCCCGACCAGCTCGAGCTGCCCGCCGACTTCCCCCGCCCGCCCGTCGCCGAACACCGCGGCGGCTCCGTGCCCCTGGCCGTCCCGCCGCAGCTGCACGCCCGGCTCGACACGTTCGCCCGCGCCCACGGCGCCACCTGCCACATGGTGCTCCAGGCCGCCCTCGCCGCCCTGCTCACCCGCCTCGGCGCCGGTACCGACATCCCCATCGGCTGCCCCACCGCCTCCCGCCCCGACAGCGCCCTCGACGACCTGGTGGGATTCTTCGTCAACCCGGTCGTGCTGCGCGCCGACACCTCCGGCGATCCCACCTTCACCGAGCTGCTGGCCCGGGTGCGCGCCACCGCGCTGGCCGCCTACGCCCACCAGGACGTGCCCTTCGACCGGGTCGTCGAACGCCTCCAGCCCGAGCGGTCCGCCGCCCGCCACCCCCTGTTCCAAGTGGTGCTGTCCTACCAGGACTTCGAGGCCCGGGCACACCTGAAGGGCCTGGACGTGCGGCGCGAGGACGTCGACTTCGGCGTCGCCAAGTTCGACCTCACCTTCAACCTCGTCGAACACCGCGGCGACGGCGAGGAGTTCGCCGGCATCGACGGCGACCTCGAGTACGACACCGCCCTGTACGAGCGGGCCACCGCCGAAGCCCTCACCGGCCGGCTGCTGCGGCTCCTCGACGCCGTCGTCACCGACCCGCAGGCGCCGGTCGGCTCCCACGACCTCCTCGAAGAGGCCGAACACGCCCGCCTGGCAGCCTTCAACGACACCGCCCGGCCCGTGCCGCGAGCCGGCCTCGCCGAACTCTTCACCGCCCAGGCCCGCCGCACCCCCGATGCGGTCGCCGTCGTCGGCGACGACGGCACCGAACTCACCTACGCCGAACTCGACGCCCGCTCCGGCGCCCTCGCCCGGCGGCTCGCCGCCGCCGGCGCCGGCCGCGAGTCGGCCGTCGCCGTCCTCCAGCAGCGCTCGGTGCACCTGGTCGTGTCCCTGCTCGCCGTCCTCAAGGCGGGCGGCTTCTACGTGCCGCTCAACACCCGCTACCCGGCCGACCGGATGCGCCTGATCACCGCCGACGTCAAGGCCCGGGTCCTGCTCACCGACCGGGCCACCGACACCGCGCACGAGTGCCGCTCCTGGGCGGGCGACGCCGACGTCCTCGTCGTCGACGAACTGCCCACCGGCGGCGAGCCGCTGCCCGTGGTGCCCGCGCACCCGCACCAGCTCGCCTACGTGATGTACACCTCCGGCTCCACCGGCAACCCCAAGGGCGTCGCCATCACCCACGGCGACGTCGCCGCCCTGGCCGCCGACACCTGCTGGCGCACCGGCAACCAGCAGCGGGTCCTGCTGCACTCCCCGTACTCCTTCGACACCTCCCAGTACGAACTGTGGGTGCCGCTGCTGTCCGGCGGGACGGTCGTCGTCGCACCACCCGGCGACCTGGACACCCGCGCCCTCGAGCGGGCGATCGTCGACGGCGGCGTCACCGGCATGTGGCTCACCTCCGGCCTGTTCAACCTGCTCGCGGAGGAGAGCCCGCACTGCTTCACCGGCGTGCGCGAGGTGTGGACCGGAGGCGACGTCGTCTCCCCGGCCGCTGTCGCCCGGGTGCTGGCCGCCTCCCCCTCGACCATGGTCGCCGACGGCTACGGCCCCACCGAGACCACCACCTTCGCCACCCACCACTTCATGCGCGCCCCGTGGCAGCAGGAGACCACCGTCCCCATCGGCACCCCCCTGGACAACACCACCTGCCACGTCCTGGACGACCGGCTGCGGCCCGTACCGCCCGGCGTCACCGGCGAGCTGTACATCGGCGGCTCGGGCCTCGCCCGCGGCTACCTGAACCGCCCCGAGCTGACCGCCGAACGGTTCGTCGCCGACCCCTACGCCCCCGGCGGGCGCATGTACCGCACCGGCGACCTGGTGCGCCTGCGGCGCGACGGCGTCCTCACCTTCCTCGGCCGCGCCGACCACCAGGTCAAGGTCCGCGGCTTCCGCATCGAACTCGGCGAGATCGAATCCGTCCTCGGCGCCCACCCCGGCATCGCGCAGAGCGCCGTCCTCGTACGCGAGGACCGGCCCGGCGACAAACGCCTCGTCGCCTACGTCGTCCCCGCGCCCGGCGCCACCGCCGACGCCACCGTGCTGCGCCGGCACGTCGCCGCCGCGCTGCCCGACTACATGGTGCCCGCCGCGTTCGTCCCCCTCGACGCACTGCCGCTGACCGGCAACGGCAAACTCGACCGCCGCGCCCTGCCCGTCCCCGACTTCGGCGCCGCCGACAGCGCCGGCCGCGCCCCGCGCACCCCCCGCGAGGAACTCCTCGCCGTGCTGTTCGCCGAGGTCCTCGGCATCGAGAAGGTCTCCATCGACGACAGCTTCTTCGACCGCGGCGGCGACAGCATCATGGTCATCCAGCTCGTCGGCCGCGCCCGGCGCGCCGGACTGCTGCTGAACGCCGCGCAGATCTTCGAGCACAAGACCGTCGCCCAGCTCGCACCCGTCGCCGAGACGCTCGCCGACACCACCCGCGAGGAACCCGCCGCCGTCGCCGCGACCGGCGACGTACCGCTCACCCCGATCATGCACTGGCTGCGCGAACGCGGCGGCCCCGTCGACGCGTTCAGCCAGACGATGGCCGTCACCGTCCCCGCCGGCCTGGACCGGGAACGGCTCGTGGCCGCCCTGCAGACACTGATCGACCACCACGACGCACTGCGCGCGGTGTTCTCCCGCGACGACGCCGACTGGACGATGCGGATCGAGGCGCCCGGCACCGTGGACGCCGCGGACTGGGTGCGCCACGTGGACGCCGCCGGCCTCGACGAGCAGGCCCTCGCCGCCCTGACCACGGCCGAGGCCGCGGCCGCCCGCGAGCGTCTCGCGCCCTTCGCCGGCCGCGGCGGGCAGGCCGTCTGGCTCGACGCAGGACCCCACCGCCCCGGCCGTCTGCTGCTGACCCTGCACCACCTCGTCGTCGACGGCGTCTCCTGGCGCATCCTGCTCCCCGACCTGAAGGCCGCCTGGGAAGCCACCGCCCCCGGCTCCGCCGCCCCCGCCCTGCCGCCCGTCACCACCTCCTTCCGGGCCTGGGCCCACCACCTGGAGCAGCAGGCCGGGCGCCCCGAGCGGGCCGCCGAACTGGCCCTGTGGACCGGGATGCTCGCGGCCGGCAGCCCACCGGTGACCGCACAGCCGCTCGACGGCCGGCTCGACACCGCCGCCACCGCCCGCGGCCTCACCCTCACCCTCGACACGACCACCACGGCCGCGCTGCTGACCACCGCGCCCGCCGCGTTCAACGGCCGCGTCGACGACATCCTGCTCACCGCGTTCGCGCTCGCCGTCACCGACTGGCGACGGCGCCGCGGACTGGGCGACAGCGACGCCGTCCTGACCGACGTCGAAGGACACGGCCGCGAACCGGGCACCAGCGGCGCCGAACTCTCCCGCACCGTCGGCTGGTTCACCAGCCTCTACCCGGTCCGGCTCGCCCTCGGCACCCTCGACGCGGCCGACGCCCTCGCCGGCGGACCCGCCGCGGGAACAGCCGTCAAACGCATCAAGGAAGCCCTGCGGCAGATCCCCGACGGCGGCATCGGCCACGGCCTGCTGCGCCACCTGGACCCCCGCACCGGCCGCAGCCTCGCCGCGCTCGCCCCGTACGGCACCCCGCCGCTCGGCTTCAACTACCTGGGCCGCTTCCCCGCCGAGGGCGCCGACGGCCTGTGGAGCGCCGCCCCCGACGCCGAGGCGATCGGCGACGGCACCGACCCCCGCCTGCCCCTCGCACACGCCGTCGAGGTCAACGCCCTCACCCTCGACGAGCCCGCCGGGCCCCGCCTGAAGGCCACCTGGACCTTCGCCGGCCGCCTCCTCGACGAGCCGGCCGTACGCGACCTGGGCGAGACGTGGTTCCGCGCCCTGAACGCACTCGTCACTCATGCCGAACGCCCGGAGGCGGGCGGCATCACCCCCTCCGACCTGTCCCTGGTCCAGCTCAGCCAGGACCAGATCGACCAGCTCGAAGCCGCGTGGAAGGTGTCCCCATGA	MLVPDDARLPLTAAQLGIWFAQARDPHSPVFNTGEYVELTGGLDADRFEAALRATVARTDALRLRFHTDAEGTVTQSVADDVPFTLHRVDVSAEDDPAAAADAWMRDVIARPLDVTCGRPLFTQALFTLGPGRHRWFQHVHHLLLDGYGFRLVAERVAAAYRAGAEAGDAEAGDTEPGIRDLLAAEADWRASDAYAQDRAHWLATPRHTPVTLAGTTAPGAPGALRRTASAGPEVLAGLDAVARAAETGRQVAFPAAVAAYVQWLTGERTVTLGMPVTARRTSAARRAPGTVANVPALHVEPRPAAPLAELVASVRDALEPLLRHQRYPYEEARRELGAVGERAYGPVVNVMPYGRALDFGGPAASVHPVSTGPVEDLKFSVYEEPDGSGARIDLEANAAVYGESETDAHLARFVRFLGAFAEAGPDTPLGRIHAAAPAAPAAAAPTTGGPALHTLFAARAAATPHAVAVSHDGDHLTYAQLDARANRLAHRLVEQGAGPERLVALTLPRSLDLVVALLAVLKSGAAYLPLDPDYPADRLAWMLEDAAPVLVLDPQAMTEDLAGYPDTAPRTAVDGAHPAYVIYTSGSTGRPKGVVIPHSNVVRLFTSTDHWFGFGPDDVWTLFHSYAFDFSVWEIWGALLHGGRLVVVPYHVSRSPGDFLDLLAREKVTVLNQTPTAFHQLDAADRARTAAPELALRYVVFGGEALDVARLADWYARRGTAARLVNMYGITETTVHVTHAPLGPGHAVPGTPSLLGGPIPDLTPRVLDAALRPVPPGFTGELYVAGAGLARGYLNRPALTAQRFPADPYGAPGTRMYRTGDLVRHLDDGTYAYLGRGDDQVKIRGFRIELGEIENVLATHPGVAQAAAVVREDRHGDLRLAAYAVPTPGTEPDVAGWRALLAGQLPAHSLPASFTLLAALPLTANGKLDRAALPAPQAPAPETADEPAPAADPGEAALRRIFADTLGTPRVGADSDFFTLGGHSLLAGRLIAAVRDTLGAEITIQDLFEAPTPAGLAARVRTAATGRPPLVPRDHGDGPRPTSYAQHRMWVLREVEGAAPTYNMPLALRLSGTLNRTALRAALYDVVVRHESLRTVYPRGEHGVTPRLLPPEQARPWVIESRVDDEQLPAALTAAAREPFNLDCQLPIRAHLFTLPGGDSVLLLLMHHVAGDGWSLRPLLGDLSTAYAARLAARAPDFPPLPVSYADFAVWQRELLGDEHDPDSLAARQLAHWESTLAGLPDQLELPADFPRPPVAEHRGGSVPLAVPPQLHARLDTFARAHGATCHMVLQAALAALLTRLGAGTDIPIGCPTASRPDSALDDLVGFFVNPVVLRADTSGDPTFTELLARVRATALAAYAHQDVPFDRVVERLQPERSAARHPLFQVVLSYQDFEARAHLKGLDVRREDVDFGVAKFDLTFNLVEHRGDGEEFAGIDGDLEYDTALYERATAEALTGRLLRLLDAVVTDPQAPVGSHDLLEEAEHARLAAFNDTARPVPRAGLAELFTAQARRTPDAVAVVGDDGTELTYAELDARSGALARRLAAAGAGRESAVAVLQQRSVHLVVSLLAVLKAGGFYVPLNTRYPADRMRLITADVKARVLLTDRATDTAHECRSWAGDADVLVVDELPTGGEPLPVVPAHPHQLAYVMYTSGSTGNPKGVAITHGDVAALAADTCWRTGNQQRVLLHSPYSFDTSQYELWVPLLSGGTVVVAPPGDLDTRALERAIVDGGVTGMWLTSGLFNLLAEESPHCFTGVREVWTGGDVVSPAAVARVLAASPSTMVADGYGPTETTTFATHHFMRAPWQQETTVPIGTPLDNTTCHVLDDRLRPVPPGVTGELYIGGSGLARGYLNRPELTAERFVADPYAPGGRMYRTGDLVRLRRDGVLTFLGRADHQVKVRGFRIELGEIESVLGAHPGIAQSAVLVREDRPGDKRLVAYVVPAPGATADATVLRRHVAAALPDYMVPAAFVPLDALPLTGNGKLDRRALPVPDFGAADSAGRAPRTPREELLAVLFAEVLGIEKVSIDDSFFDRGGDSIMVIQLVGRARRAGLLLNAAQIFEHKTVAQLAPVAETLADTTREEPAAVAATGDVPLTPIMHWLRERGGPVDAFSQTMAVTVPAGLDRERLVAALQTLIDHHDALRAVFSRDDADWTMRIEAPGTVDAADWVRHVDAAGLDEQALAALTTAEAAAARERLAPFAGRGGQAVWLDAGPHRPGRLLLTLHHLVVDGVSWRILLPDLKAAWEATAPGSAAPALPPVTTSFRAWAHHLEQQAGRPERAAELALWTGMLAAGSPPVTAQPLDGRLDTAATARGLTLTLDTTTTAALLTTAPAAFNGRVDDILLTAFALAVTDWRRRRGLGDSDAVLTDVEGHGREPGTSGAELSRTVGWFTSLYPVRLALGTLDAADALAGGPAAGTAVKRIKEALRQIPDGGIGHGLLRHLDPRTGRSLAALAPYGTPPLGFNYLGRFPAEGADGLWSAAPDAEAIGDGTDPRLPLAHAVEVNALTLDEPAGPRLKATWTFAGRLLDEPAVRDLGETWFRALNALVTHAERPEAGGITPSDLSLVQLSQDQIDQLEAAWKVSP	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	466.01	gnl|BL_ORD_ID|4935|hsp_num:0	5928			567	1629	colistin A; colistin B
BGC0000952.1|Pristinamycin_14 # 41091 # 41840 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.748	BGC0000952.1|Pristinamycin_14 	41091	41840	-	Loose	470	48.9062	sdiA	39.06	3000826	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGGAAGCAGGAACCGGCCTCGGCCGGACGGCGCCCGCGCACGGCGGCAAGGCCTCCGTCCTGCGCATGCTGCCCGGCGGGGCGACCGCCGCACCGGGAGTGCGGCTGTTCCTCGTCGGCGGTGACGCGCTCGCCCGGGCCGGGATCCGCTCCCTGCTCGACGGGCAGGGCGGCATCAGTGTCATAGGGGAGGACGAGCCCGGCCCGCGGGCCCTGGCAGCGTTGCGGGCCCAGGCGCCCGACGTGCTCGTCGTCCACGGGCTGCGCGAGGCGCACGAGGCCGACGCGCTGCTGCGCGAGGTCGACCCCGGCATACGGGTGCTCACCGTCGGCGGGGCCGAGCCCAAGGGCCGGACCACGGCCGTCCTGCACGGCCATCTGCCCCACTCCACCACCTCCCAGCAGCTGGCCGCCGCCGTCTCACTGGCCGCCGCCGGCTACTCGCTGACCCGAGGCCCGCTGCCCCCCACCACCACCGAACCCGCCCCGGCCGCCACGCCGGAGAAGGCCGCACCCCGGCCCCGGGCCGCCGCCACCGTCTCCGACGTGCCGCCCGAGCAGCTCACCGGCCGCGAGTGCCAGATCCTCGACCTGGTGGCCCGCGGACTGTCCAACACCGAGATCGCCCAGTCGCTGACGCTGTCCGAACACACCGTCAAGACCCATGTGCAGAACCTGCTGAACAAGCTGCGGCTGCGCAACCGCGTGCACGTGGCCATCTACGCCTTCGAGACCGGCCTGCGCTGA	MTEAGTGLGRTAPAHGGKASVLRMLPGGATAAPGVRLFLVGGDALARAGIRSLLDGQGGISVIGEDEPGPRALAALRAQAPDVLVVHGLREAHEADALLREVDPGIRVLTVGGAEPKGRTTAVLHGHLPHSTTSQQLAAAVSLAAAGYSLTRGPLPPTTTEPAPAATPEKAAPRPRAAATVSDVPPEQLTGRECQILDLVARGLSNTEIAQSLTLSEHTVKTHVQNLLNKLRLRNRVHVAIYAFETGLR	MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLRTTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVTQCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRFSKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI	103.75	gnl|BL_ORD_ID|207|hsp_num:0	228			525	717	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000952.1|Pristinamycin_15 # 42105 # 42623 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.707	BGC0000952.1|Pristinamycin_15 	42105	42623	+	Loose	200	25.7942	ANT(3'')-IIc	26.42	3004091	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGGAGACATTCACCGGTCACGGCGACCGGCTCGCGGCATTCGGCAACCAGCTGATCGCGGTCCATCTGTGGCTGCGCGAGGAACTGGCGCGGCTCGCCGACGACGTCGACGCCTTCCTGGAGGGCGGCGAACGGCCGCGGGAGCTGCGGGCCCACTGCCTGACGTTCTGCTCCGCGGTGCGCCGCCACCACACCGAGGAGGACGACGCCGCCTTCCCCGCGCTGGCGCAGCAGTTCCCGGAACTGCGGCCGGTGCTGGAGGAGTTGGAGAACGACCACCACACGGTGGCGGACATCCTGCGCCGCATCGAGGAGCTGCTGGGCGGCCTCGGCACGGGCGAGGGCGCGCTGCCCGCGCAGGAGGTGCGCAAGGAACTGGACGGTCTGGCGGCCCTGTTGGAGTCCCACTTCGTGTACGAGGAGAAGAAGATCGTCACGGCCCTGAACGGCCTGTCCGCGCCGCTGCCGGGCGGCGTGGTCCTCCAGGACGTCATCCAGGACGTGTCCGGGCAGGAGTAG	METFTGHGDRLAAFGNQLIAVHLWLREELARLADDVDAFLEGGERPRELRAHCLTFCSAVRRHHTEEDDAAFPALAQQFPELRPVLEELENDHHTVADILRRIEELLGGLGTGEGALPAQEVRKELDGLAALLESHFVYEEKKIVTALNGLSAPLPGGVVLQDVIQDVSGQE	MSETLQLEQLTGYLQQLLGESLFAIYLYGSAVDGGLGPESDLDILVVVSQALTLPQRQQLAETLLQISHPIGAAQRALEVTIVRKDHILSGSYPLSYELQFGEWLRDELSQGDMLSEHADPDLSILLKKAQLHHRSLFGPSLTQWSVEIPDQQLWQAMADTYPSIVAHWDEDADERNQILALCRIYFSLVTNEIAPKDQAAQWVIAQLQPQHQPVLQRMVQEYKGEIEKQNWQQQHHALQPVVDFLSSKIDERFKQKKV	66.41	gnl|BL_ORD_ID|2357|hsp_num:0	2755			510	669	spectinomycin; streptomycin
BGC0000952.1|Pristinamycin_17 # 43633 # 45435 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.760	BGC0000952.1|Pristinamycin_17 	43633	45435	-	Loose	700	28.8758	ACT-55	25.86	3006250	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	GTGACCGCACCCGTGACCGCGCCCGCCCCGGCAGCGGCGGGCCACCGACCGAGCACCCCCGGGCCCGCCACGGGCCCGGGGGCGCACGGCGGCGCCCCGCCCGGCGCCGCCGAGCGGGCCGCCTGGCTGGAGAACCTCCTCGGCGACCCCGACGACCCGCGCAACCCGCACGGCTACACACCCCTCCTGGACGCCGACGACCGCCGCGAGATCCCCGCCGCCACCGAAGCGCTGCTCACCGACGCCGGACTCACCGCCGAACTCGTCCCCCACGAACTCGGCGGCCGCCTCATCCGCCCCGACCTCCTCGCCCAGGTCCTGCGCCCTCTCTTCCGCCGCGACGTCGCCCTCGGCTTCGGCCACGGCATCACCTCGCTGTTCGGCGCCTCCGCCGTCTGGGCGGCCGGCGACACCGCACAGCGGGAAGCGACCGCCCGCGTGCTCCTGGCCGGCGGCCGCACCCCGATCCTCCACCACGAACTCGCCCACGCCAACGCGATCCTGCGCGACGAGTTCACCGCACGACCCACCCCCGACGGCGGCTTCGTCCTGTCCGGACGCAAGGACGTCGTCATCAACGCCGACCGGGCGGACGCCTACGTCATGTACGCCCGTACGGCGTCCTCGACCGGCCCACGAAGCCACTCCGTGCTGCTGCTCGACCCCGAGCGGCTGCCGCCCGGCGGCCTGCGCCGGCTGCCGCGCGCCCTCACCCCGGGCATGCGCGGCAGCCGCTTCGCGGGCCTCGAGTTCACCGACTGCCCCGCCGGGGCCGACACCCTCGTCGGCGACCTCGGCGACGGCGTCCCGCTCGCCCTGCGCACCTACCAGGTCAACCGCTGCCTCATCCCCGCCACCGTCGTCGCCGGCGTCGACAGCGTCCTGCGCTTCGCCGTCCGCGCCGCCGTCACCGGACGGCCCGCCGGCGTCCCGCCCCGCCGCTGGCACACCGTGCTGGCCGGCGTCTTCGCCGACCTGCTCGCCTGCGACAGCATGGCCGTCACCGGACTGCGCGCCCTGAGCCTGCTGCCCGACAGCTCCCACCTGCTCGCCGCCGCCGTCAAGATGACCATGCCCGACCTGCTCCGCGAGGACCTCGAGGAGCTCTCCACCGTCCTCGGCGCGCACGGCTACGACCGCGGCCCGCGCTACGGCGGCTTCCAGAAACTCGTCCGCGACCTGCCCGTCGCCGGACTCGGCCACGCCGGCACCGCCGCCTGCCAGGCCGTCATCGTGCCCCAACTGCCCACCCTCGCCCGCCGCTCCTGGTTCCGCACCGACGAACCGGCCGGCCGGCTGTTCCTGCCCCGGGCGCCGCTGCCCGCCTTCGACTACCGCGCCCTCACCCTCACCGGCAGCGACGACGTCCTGACCGCGTCCCTGATCGGCACCGCCGAACGCCTCGCCCCCCTGCGCACCACCTCGGACGCCTGGGCCGCCCTCGCCGACCTCGCCGACGCGTTCGTCCAGGAGATGCGCGCCCTGCGCGAACAGTGCGCCGCCCTCCCCGACATCACCCACGCCGCACTCGTCGACCCCCGCGTCTGCGCCCTGGCCGACCGCTACGCCCTGGTCCTCGCGGCCGCCGCCTGCCTGGGCGTGTGGCAGGGCCAGGACGGCACCGGCACCTTCCTGTCCGACCCGGCATGGGCCGTCCTCGCCCTCACCCGCATCGGCCGCAGACTCGGCGTCCCGGTCCCCGAACTCCCCGGGAACACCACCAAGGCGGTCCTCGAAGAGGTGCTCGCGCGCTACCGGGACCACCGCAGCTTCGACCTGTACGACACACGGCTCGCCGGCTGA	MTAPVTAPAPAAAGHRPSTPGPATGPGAHGGAPPGAAERAAWLENLLGDPDDPRNPHGYTPLLDADDRREIPAATEALLTDAGLTAELVPHELGGRLIRPDLLAQVLRPLFRRDVALGFGHGITSLFGASAVWAAGDTAQREATARVLLAGGRTPILHHELAHANAILRDEFTARPTPDGGFVLSGRKDVVINADRADAYVMYARTASSTGPRSHSVLLLDPERLPPGGLRRLPRALTPGMRGSRFAGLEFTDCPAGADTLVGDLGDGVPLALRTYQVNRCLIPATVVAGVDSVLRFAVRAAVTGRPAGVPPRRWHTVLAGVFADLLACDSMAVTGLRALSLLPDSSHLLAAAVKMTMPDLLREDLEELSTVLGAHGYDRGPRYGGFQKLVRDLPVAGLGHAGTAACQAVIVPQLPTLARRSWFRTDEPAGRLFLPRAPLPAFDYRALTLTGSDDVLTASLIGTAERLAPLRTTSDAWAALADLADAFVQEMRALREQCAALPDITHAALVDPRVCALADRYALVLAAAACLGVWQGQDGTGTFLSDPAWAVLALTRIGRRLGVPVPELPGNTTKAVLEEVLARYRDHRSFDLYDTRLAG	MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEITDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADATLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVGGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILEALQ	157.48	gnl|BL_ORD_ID|3108|hsp_num:0	4146			315	942	
BGC0000952.1|Pristinamycin_18 # 45432 # 46388 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.710	BGC0000952.1|Pristinamycin_18 	45432	46388	-	Loose	540	25.7942	CIA-3	22.7	3004770	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	CIA beta-lactamase	ATGTCCGCTGAGCGAGTGCACGCAACGACGCACGAGGTGAACGTGGCCGCGCCCGCCGGCGTGGTCTACGGCCTGATCTCCGACGCCGTCCAGTGGCCGCTGTTCTTCCCGCCCAACGTCCACGTGGAACGCCTGGAGTTCGACGGCGCCAGCGAACGCCTGCGCATGTGGGCCACCGCCAACGGACAGGTCAAGTCCTGGACCTCCCGCCGCGTCCTCGACCCCGCCCGGCGCCGCATCGAGTTCCGCCAGGAACTGCCCGCCTCCCCGGTGCAGTCCATGGGCGGCACCTGGATCGTCGAACCGCTCGACGCGAACCGGTCCAAGCTGACCCTGCTGCACGACTTCACCGTCGCCGGCGACGCCGCCGACGACGTCGCCTGGGTCGAACGCGCCACCGACACCAACAGCCGCGCCGAACTGGACAACCTCAGCCGGCTCGCCGAACGCTGGTCCCAGCTCGACGACCTCGTCCTGTCCTTCGAGGACTCCGTCCGCGTCAACGGCCCCGCCGAACTCGTCTACGACTTCCTCTACCGGGTGGCGGACTGGCCCCAGCTCGTCCCGCACGTCTCCCGCCTGGAGCTGACGGAGGACCAGCCCGGCGTCCAGGTCATGGCCATGGACACCGTCACCGCCGACGGCTCCACCCACACCACCGAGTCCGTCCGCGTCTGCTTCCCCCACGCCGGACGCATCGTCTACAAGCAGACCGCCACCCCGCTGCTGATGGCCGCCCACACCGGCGAATGGTCCGTCGTCCCCGACGAGACCGGCGTCACCGTCACCTCCCAGCACAGCGTCGTCCTGCGCCCGGAGAACATCGAGTCCGTCCTCGGCCCGGACGCCGACGTGCAGACCGCCCGCCGCTACGTCCGCGAGGCCCTGGGCCGCAACAGCGGCGCCACCCTCGCCCTCGCCAAGAAGCACGCGGAGAGCGCGGTCCGCGTCCTGTGA	MSAERVHATTHEVNVAAPAGVVYGLISDAVQWPLFFPPNVHVERLEFDGASERLRMWATANGQVKSWTSRRVLDPARRRIEFRQELPASPVQSMGGTWIVEPLDANRSKLTLLHDFTVAGDAADDVAWVERATDTNSRAELDNLSRLAERWSQLDDLVLSFEDSVRVNGPAELVYDFLYRVADWPQLVPHVSRLELTEDQPGVQVMAMDTVTADGSTHTTESVRVCFPHAGRIVYKQTATPLLMAAHTGEWSVVPDETGVTVTSQHSVVLRPENIESVLGPDADVQTARRYVREALGRNSGATLALAKKHAESAVRVL	MKKITFLLLMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDEKLPLLSVFKFHLACAVLDMADKGKFSTYQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIITYTVAQSDNNTCDFLLRLIGGPQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTNATVSLLKKFYDGKLLTKKSTDFLMQIMLATTTGTNKIVEQLPKGTPVAHKTGSSGKPDNILTVAENDMGIITLPNGKHYAIAVFVSNSTETEKVNTRMVSDISKIVWDNFNK	108.90	gnl|BL_ORD_ID|2565|hsp_num:0	3572			393	813	
BGC0000952.1|Pristinamycin_19 # 46405 # 47199 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.709	BGC0000952.1|Pristinamycin_19 	46405	47199	-	Loose	600	24.6386	AER-1	31.58	3002481	protein homolog model	n/a	n/a	penam	antibiotic inactivation	AER beta-lactamase	ATGACCGCACCGTCGCCGGCGACGCCGCCGGTCGCCCTGGTCACCGGCGCCACCAGCGGCATCGGCCTCGCCGTCGCCCGCGACCTCGGCCGCCGCGGCCACCGCGTCTTCATCTGCGCCCGCACCGCCCTGGAGGTCAAACAGACCGTCGAGGACCTCCGCGACGAAGGCCTGGAGGCCGAGGGCGCCGCCGCCGACGTCCGCTGCCGCGACTCGGTGGCCGCCCTCGTGCGCACCGTCCTGGACACCTACGGACCCGTCACCGTCCTCGTCAACAACGTCGGACGCAGCGGCGGCGGACCCACCGCCGACATCGCCGACGAACTCTGGTACGACGTCATCGACACCAACCTCAACAGCGTCTTCCTGCTGACCCGCGAAGTCCTCAAGAACGGCGGCCTCGCCGACGCCACCTGGGGACGCATCATCAACATCGCCTCCACCGCGGGAAAACAGGGCGTCCTGCTCGGCGCCCCCTACTCCGCCTCCAAGCACGGCGTCGTCGGCTTCACCAAAGCCCTCGGCAAGGAACTCGCCCCCGCCGGCATCACCGTCAACGCGGTCTGCCCCGGCTACGTCGAGACCCCGCTGGCCGAACGCGTCCGCCAGGGCTACGCCGCCGCGTGGGACACCACGGAGGAATACGTACAGGAGCAGTTCGAGGCCAAGATCCCCCTCGGCCGCTACACCACCCCCGAAGAAGTGGCCGCCCTGGTCGGCTACCTCACCACCGAACACGCCGCCTCCATCACCGCCCAGGCACTCAACGTCTGCGGCGGCCTGGGCAACGTCTGA	MTAPSPATPPVALVTGATSGIGLAVARDLGRRGHRVFICARTALEVKQTVEDLRDEGLEAEGAAADVRCRDSVAALVRTVLDTYGPVTVLVNNVGRSGGGPTADIADELWYDVIDTNLNSVFLLTREVLKNGGLADATWGRIINIASTAGKQGVLLGAPYSASKHGVVGFTKALGKELAPAGITVNAVCPGYVETPLAERVRQGYAAAWDTTEEYVQEQFEAKIPLGRYTTPEEVAALVGYLTTEHAASITAQALNVCGGLGNV	MYVLSVEKPTLRNKFAAGIGVVLVCVVASFIPTPVFALDTTKLIQAVQSEESALHARVGMTVFDSNTGTTWNYRGDERFPLNSTHKTFSCAALLAKVDGKSLSLGQSVSISKEMLVTYSPITEKSLSPETVTFGKICQAAVSYSDNTAANVVFDAIGGATGFNAYMRSIGDEETQLDRKEPELNEGTPGDVRDTTTPNAMVNSLRKILLGDALSASSRSQLTQWMLDDQVAGALLRASLPSDWKIADKTGAGGYGSRSIVAVIWPPSKQPLVVGIYITQTKASMQASNQAIARIGVVLKDTVAP	86.84	gnl|BL_ORD_ID|1061|hsp_num:0	1149			309	423	
BGC0000952.1|Pristinamycin_20 # 47196 # 48977 # -1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.749	BGC0000952.1|Pristinamycin_20 	47196	48977	-	Loose	550	186.808	Nocardia farcinica rox	37.88	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGTCCGATGACCGCCGGCCCGACGTCCTGGTCGCCGGCGCCGGCCCGGTCGGCCTGACCGCCGCCCACGAACTGGCCCGCCGCGGCCTGCGCGTCCGCCTCGTCGACGCCGCCACCGGCCCCGCCCGCACCAGCCGCGCCGTCGCCGTCCACCCGCGCACCCTGGAAACCCTCGACCAGATGGGCACCGCCGCACCCGTCATCGAAGCCGGCCGCAAGAACCGGGCGTTCACCATGTTCGCCTCCGGCCGCCGGCTGGTGCGCCTGGAGGCCGACTACCGCAGCATGCCCACCCGCCACCCCTACACCGTGATCATCGAGCAGACCCGCACCGAGGCCGTCCTGCGCGACGCCGTCGCCCGGCTCGGCGTCGAGATCGAATGGGGCGTACGGCTCACCGGCCTCGAGCAGGACACCACCACCGTACGAGCCACCCTGCGGCACGCCGACGGCACCGAGGAGATCTGCGAGACACCCTGGCTGGTGGGCTGCGACGGCGGCCACAGCACCGTACGCAAACAGCTCGGCCTGCCCCTGATCGGCGAGAGCCGCGACACCTGGCTGCTGGCCGACGCACCCGTACGCACCGACCTCGAACCCGACAGCATCTACTGGGTCCACACCGGCAAACAGGCCATGATGATGGTGCCCTACGCCCGCCCGGGCCACTGGCGGCTGCTGGACACCGCCCCCCGGACCCCCGACGCGGCCGGCGCCGCCGAACGCATCGCCGACCGCCTCACCACCGGCCTCGGCCACCAGGTCCACGTTGGCGACCCCGAATGGGTCTCCGTCTTCACCTTCCAGCAGCGCATGGTGCCCCGCATGCACCAAGGCCGCGTCTTCGTCGCCGGCGACGCCGCCCACGTCCACAGCCCGGCCTCCGGACAGGGCATGAACACCGGCATCCAGGAGGCCTACAACCTCGCCTGGAAACTCGCCATGGTCCACCAGGGCCACGCCGGCCCCGCGCTCCTGGACACCTACAGCACCGAACGCGTCCCCATCGGCAAGCAGCTCCTCGGCTCCACCCGCACCGCCACCTTCCTCGTCCAGCTCAAGAACGCCCTCGCCTCCCTCGCCCTGCCCGCCGTCTTCACCGTCGTACGCGCCGTGCCCCCGCTGCGCCGCGCCATCCAGCGCAAGGTCCTCGGCGGCATGTCCGGACTGCGCATCGACTACGCCACCAGCCCGCTGACCACCGGCGCAGGACCCGAACCCGTCCCCGTCGCCGCGCCCGTCGCCGCGCCCGTGTTCGTACCCAGGCACCGCCATGTGCCCGCCCCCGGCGAACGCGCCGCCACCGCCACCGCCCGCGAACCCGCCTCGCCCGGCCCGCGCGCCTTCGCCGACGAACTGCGCGACGTGCGCTGGACCCTGCTCGTCGCCCCCGGCGCCCACACCGCCGCCGGCACCCCCGTCCGCACCGCCACCGACGCCGCCGCCCGCCACGGCGCCTGGCTGTCCGTGCGCACCGTCGGCGACACCACCACCCCCGGCCCACGCCCCCTGCCCGACCCCGACGGCGCCCTGCGCCGCGCCCTGGGCCTCGCCTCCGGCGCCTGGGCGCTCATCCGCCCCGACGGCTACCTCGCCGCCCACGGCGGCCTGCTCACCCCCCGCGCCCTCGACGAGGCCCTGCGACCGCTGTCCCTGACAGCACCGCACCAGCCCCACAGCACACCTGAGTCCCTTCTCGAGCGGGCCTCGTCCGGCCGTCGAGCGGACCGGGACACCGTCGACAGCACCGTCGGCGCACCGCACAAGGAGGCACAACGATGA	MSDDRRPDVLVAGAGPVGLTAAHELARRGLRVRLVDAATGPARTSRAVAVHPRTLETLDQMGTAAPVIEAGRKNRAFTMFASGRRLVRLEADYRSMPTRHPYTVIIEQTRTEAVLRDAVARLGVEIEWGVRLTGLEQDTTTVRATLRHADGTEEICETPWLVGCDGGHSTVRKQLGLPLIGESRDTWLLADAPVRTDLEPDSIYWVHTGKQAMMMVPYARPGHWRLLDTAPRTPDAAGAAERIADRLTTGLGHQVHVGDPEWVSVFTFQQRMVPRMHQGRVFVAGDAAHVHSPASGQGMNTGIQEAYNLAWKLAMVHQGHAGPALLDTYSTERVPIGKQLLGSTRTATFLVQLKNALASLALPAVFTVVRAVPPLRRAIQRKVLGGMSGLRIDYATSPLTTGAGPEPVPVAAPVAAPVFVPRHRHVPAPGERAATATAREPASPGPRAFADELRDVRWTLLVAPGAHTAAGTPVRTATDAAARHGAWLSVRTVGDTTTPGPRPLPDPDGALRRALGLASGAWALIRPDGYLAAHGGLLTPRALDEALRPLSLTAPHQPHSTPESLLERASSGRRADRDTVDSTVGAPHKEAQR	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	125.37	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1032	rifampin
BGC0000952.1|Pristinamycin_21 # 48967 # 49278 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.721	BGC0000952.1|Pristinamycin_21 	48967	49278	-	Loose	1080	25.409	vgaB	32.69	3000118	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	vga-type ABC-F protein	ATGGTGACCTTCGTCAACAAGCTGACCGTGCACGGCGACCACGACGCCTTCCTCGCCGTCCGCGCCCGCCTCACCGCCTACATGTCCGCCCAGCCCGGCTACGTCAGCCACCAGAACCTGCGCGCCCTCGGCGCCGGGAACGTCCACCTCGAGATCGCCGTCTGGGACAGCGCGGAGGCACACCGCGCCGCCGTCGGCAGCGACGGCTTCCGCGCCATCGTGGCCGACCTCAAGCCACTGGTGACCGCCGAACCCGCCATGTACGAGACCGAGGACGCCGCCGCCCCGCTGGAGGCGGCCGGTGTCCGATGA	MVTFVNKLTVHGDHDAFLAVRARLTAYMSAQPGYVSHQNLRALGAGNVHLEIAVWDSAEAHRAAVGSDGFRAIVADLKPLVTAEPAMYETEDAAAPLEAAGVR	MLKIDMKNVKKYYADKLILNIKELKIYSGDKIGIVGKNGVGKTTLLKIIKGLIEIDEGNIIISEKTTIKYISQLEEPHSKIIDGKYASIFQVENKWNDNMSGGEKTRFKLAEGFQDQCSLMLVDEPTSNLDIEGIELITNTFKEYRDTFLVVSHDRIFLDQVCTKIFEIENGYIREFIGNYTNYIEQKEMLLRKQQEEYEKYNSKRKQLEQAIKLKENKAQGMIKPPSKTMGTSESRIWKMQHATKQKKMHRNTKSLETRIDKLNHVEKIKELPSIKMDLPNREQFHGRNVISLKNLSIKFNNQFLWRDASFVIKGGEKVAIIGNNGVGKTTLLKLILEKVESVIISPSVKIGYVSQNLDVLQSHKSILENVMSTSIQDETIARIVLARLHFYRNDVHKEINVLSGGEQIKVAFAKLFVSDCNTLILDEPTNYLDIDAVEALEELLITYEGVVLFASHDKKFIQNLAEQLLIIENNKVKKFEGTYIEYLKIKDKPKLNTNEKELKEKKMILEMQISSLLSKISMEENEEKNKELDEKYKLKLKELKSLNKNI	18.66	gnl|BL_ORD_ID|1678|hsp_num:0	1817			1185	1329	virginiamycin M1; dalfopristin
BGC0000952.1|Pristinamycin_22 # 49322 # 50932 # -1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.747	BGC0000952.1|Pristinamycin_22 	49322	50932	-	Loose	1000	46.9802	almE	22.04	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGCCGCGATTCACGCACCCGGAACTGCCCCTGGACGGACTGCTGCGCCAGGCCGCCGTCCGGGACCCCGACGGCACCGCCCTGACCTGCGGGCAGCACACCCTCACCTACGCCGAACTCGACGCCCGCGCCGACCGCGTCGCCCACTACCTCCTGCGCGCCACCGGCCGGCCGGGCACCACCGTCGGCGTGGCGAACACCCTCGACGCCGCGTTCGCCGCCACCTACTACGGCACCAGCCGCAGCGGCAGCACCATCGCCCTGGTCAACCCGCTCATCGGCGAGGCGGCACTGCGGCACGTGTTCACCGCCGCCGCGATCGAGATCGCGTTCGTGCCCTGCGCCACCGCCGAACTGCTCACCAAGATGCGCGAGCAACTGCCCCGCCTGCACACCATCGTCGTCACCGACGCCGACGACGGCGTGGTCCCCGCCGACGCCACCCCGCTCCACGTCGCCCTGCACGGCGCGGACGACGGGCCGGCCGCACCCGCCCACGGACCGGCCGACCTGTCGGCGACCGTGTGCGTGCAGTTCACCACCGGCACCACCGGCCGTCCCAAGGGCGTGCGCCTGACCCACCGCAACCTGGTCGCCAACGCCCACCAGATCGCCCTCGCCCACGGCCTCGGCCCGGACTCCGTCACCCTCAACCACCTGCCGCTGTTCCACGTGATGCACCTCAACTCGGCCGTGTGCGCCGGAGCCGCGCAGGTGCTGTGCCCCGACGGCGACCCCCTCGCCTCCCTCGCGCTGGCCGCCCGCACGGGCGCCACCCACTACTACGGGCTCCCCGCCCGCCTGCACCGCCTCGCCGCCGACCCGCGACCGGCCGCGTCCCCCGACGCCGTCCCCGCCCTGCCCCGGCTCACCGCCGTCCTGTCCGGCGGCACCGCGCTCGCGCCCGCCGCCGCCCGCCGGCTGAGCCAACTGCTCGGCGTCCCCGTCGTCCAGGGCTACGGGATGGCCGAACTCTCCCCGCTGTCCCACAACCAGCGCCTCGACGACACCCGTCCCGGCGCCGTCGGACACCCCCTGCCCGGCACCGAGTCCCGCATCGTCGGCCTCGACTCGCGCGAGGTGGCGGACGTGTGGGCCACCGGCGAAGTGCAGGTCCGCGGACCGCAGGTGATGGCCGGCTACCTCGACGACGACGAACCCTCACCGATCGACGCCGACGGCTGGTTCTCCACCGGCGACATCGGCTACCAGGACGCCGACGGCGTCCTCCACCTCGTCGACCGGCTCGGCGACGTCTTCAAGTACGACAACGAACTCGTCTCACCGTCCGCCGTCGAACGGATCATCGCCGACGACCCCCGCGTCGCCGAATGCGTCGTCGTCGGCTGGCCCGACGCCGTGCACGGCGCCGTCGTATGGGCCGGCATCGTCCTGCGCGAGACCCCCGGGCCCCCGCAGCACGCGGCCCACGCCGTCCTCGACGTCCTCGACGCGATCACCGAGAAGGCCAACTCCCGGCTCGCCCACTTCGAACGCATCCGCCGCGTCGAAGCCCTCGACACCGTCCCGCGCACCCCCACCGGCAAACCCCGCCGCCAGGAACTGCGCCGCCGGCTGCGCGACCGCGCCGCCGCAGAAGCCGCCGCCTGA	MPRFTHPELPLDGLLRQAAVRDPDGTALTCGQHTLTYAELDARADRVAHYLLRATGRPGTTVGVANTLDAAFAATYYGTSRSGSTIALVNPLIGEAALRHVFTAAAIEIAFVPCATAELLTKMREQLPRLHTIVVTDADDGVVPADATPLHVALHGADDGPAAPAHGPADLSATVCVQFTTGTTGRPKGVRLTHRNLVANAHQIALAHGLGPDSVTLNHLPLFHVMHLNSAVCAGAAQVLCPDGDPLASLALAARTGATHYYGLPARLHRLAADPRPAASPDAVPALPRLTAVLSGGTALAPAAARRLSQLLGVPVVQGYGMAELSPLSHNQRLDDTRPGAVGHPLPGTESRIVGLDSREVADVWATGEVQVRGPQVMAGYLDDDEPSPIDADGWFSTGDIGYQDADGVLHLVDRLGDVFKYDNELVSPSAVERIIADDPRVAECVVVGWPDAVHGAVVWAGIVLRETPGPPQHAAHAVLDVLDAITEKANSRLAHFERIRRVEALDTVPRTPTGKPRRQELRRRLRDRAAAEAAA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	96.40	gnl|BL_ORD_ID|4935|hsp_num:0	5928			483	1641	colistin A; colistin B
BGC0000952.1|Pristinamycin_23 # 51378 # 52454 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.685	BGC0000952.1|Pristinamycin_23 	51378	52454	+	Loose	700	72.0182	CMY-38	26.29	3002049	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGACGCAGACGACGATCGACCGGCCGGGGGTCTCGGCTCTTCAGGAGGCCGTGCAGGGCGCGGCGGACCGGCTGGTCCAGGCCGGTGCGGCCGGCGTGCAGTTCCGGGTCACCCGGGGGGACAACTCCTTCGTCGTCACCTCGGGGATCGCGGAGCTGGGCTCGGACCGGCCGGTTCCCGCGGACGGCCGTTTCCGTATCTCGTGCATCACCAAGCCGTTCGTGTCCGTGGTGGTGCTGCAGCTGGTCGCCGAGGGCCGCCTCGACCTGGACCGCACGGTGGAGAGCTACCTGCCGGGGCTGCTGCCGTACGGCGAGAAGATCACCGTCCGGAACCTGATGCAGCACACCAGCGGCCTGTACAACTACATGGACTCGTTCCAGAAGCCGGGCGACCGGTTCCTGCGCGACCGCTACAAGCACTACGAGCCCGAGGACCTGATCGCGATCGCGGCGGCCAAGCCGCTGGAGTTCGAGCCGGGCACGAAGTTCGCGTACTGCAACACCAACTACTTCATCGTCGGCCTGCTCATCAAGAAGATCACGGGCCGCTCCTACCGCGAGGAGATCACCGAGCGGGTGCTGGAGCCGCTGGGGCTGAAGGAGACGACGCTGCCGGGCGACGACCCGAACATCCCCGGGCCGCACGCCCGCGGCTACATGCAGATCGGCGGCGAGCCGGTCGACGTGACGCTGATGAACCCCTCGGAGGCGGGCTGCGCGGGTGAGATCATCTCCACCACGGCGGACCTGGACCGGTTCTTCACGGCCCTGTTCAGCGGCGAGCTGCTGAACGAGCCGGAGTTCACCGAGATGACGACGCCGCTGCCGCCGGAGATGATCGAGAACCTGCCGATGGGCATCGGCTACGGCCTGGGCATCATGAAGCTGGAGAACGACGACGACCTGGACCTGTGGGGCCACGGCGCCGGCATCCCCGGCTACGCCACGTTCGCGGCCACCACCCGCGACCGATCCGCCCGGGTGCAGCTGTCGTTCACGATCGGCGACAAGGACTTCGGCCCGGAGGCCGAGCAGGCCGTCATCCGCGGTGTCAACACCGCCCTGTGCTCCTGA	MTQTTIDRPGVSALQEAVQGAADRLVQAGAAGVQFRVTRGDNSFVVTSGIAELGSDRPVPADGRFRISCITKPFVSVVVLQLVAEGRLDLDRTVESYLPGLLPYGEKITVRNLMQHTSGLYNYMDSFQKPGDRFLRDRYKHYEPEDLIAIAAAKPLEFEPGTKFAYCNTNYFIVGLLIKKITGRSYREEITERVLEPLGLKETTLPGDDPNIPGPHARGYMQIGGEPVDVTLMNPSEAGCAGEIISTTADLDRFFTALFSGELLNEPEFTEMTTPLPPEMIENLPMGIGYGLGIMKLENDDDLDLWGHGAGIPGYATFAATTRDRSARVQLSFTIGDKDFGPEAEQAVIRGVNTALCS	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLNAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKNYPNPVRVEAAWRILEKLQ	93.96	gnl|BL_ORD_ID|1474|hsp_num:0	1613			138	810	
BGC0000952.1|Pristinamycin_25 # 53315 # 54178 # -1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.726	BGC0000952.1|Pristinamycin_25 	53315	54178	-	Loose	150	31.5722	nimB	44.44	3004655	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic inactivation	nitroimidazole reductase	GTGGACACCGCCACCACCTACAAGACGAAAGTCACCGCCGCCTTCAACAAGGCCGCGGCGGCCTACGACCGGCTCGGGGTCGAGTTCTTCACCCCCATGGGCCGCCGGCTCGTCGAGCACGCCCGCCCGCAGCCCGGACAGCGGCTCCTCGACGTCGGCTGCGGCCTGGGCGCCACCCTGCTGCCCGCCGCCGACCGGATCGGCCCCACCGGCCACGCGCTCGGCATCGACATCGCAGAGGCGATGATCGAACAGGCCGGCCAGGAGGCCCGCCGCCAGGGCATCGACAACGTCGAACTGCGGGTCATGGACGGCGAACACCCCGACCTGCCCGCCCGGTCCTTCGACCTCGTCCTGGGCAGCTACAGCGTCATCTTCCTGCCCGACGCCCGCGCCGCCCTCGCCCGCTACGCCGACCTGCTGCGCGACGGCGGCCGAATCGCGTTCACCAGCCCCGTCTTCCACAAGGACCAGTTCCCCTTCCTGCCGCCGCTGTTCAGCCGCTGGATCCCCATGTCGCTGCTCCAGCACCTGCCGCCCGCCTGGCACCCCGAGCAGCTGCGGCGCCAGCTGCACTCCTGGCTCGAGGACCCCGCCGACCTCGAAGCCGCTCTGCGGCAGGCCGGATTCACCGACACCGTCATCACCGACGAGGTGGTGGAGATGACCGCCGCGAGCGGCGAGGACTGGGTCGAGTGGTCCCACACCCAGGGCATGCGCCTGCTGTGGCAGCACCTGCCCACCGACGAGGCCGCCGCCCTGCGCACCCGCCTGACCGGCGAACTCGACGCCCTGCGCGGCGCCGACGGCCTCATCCGCATCGACGTCCCCGTCCGCTACGTCACCGCCACCGTCGCCCGCTGA	MDTATTYKTKVTAAFNKAAAAYDRLGVEFFTPMGRRLVEHARPQPGQRLLDVGCGLGATLLPAADRIGPTGHALGIDIAEAMIEQAGQEARRQGIDNVELRVMDGEHPDLPARSFDLVLGSYSVIFLPDARAALARYADLLRDGGRIAFTSPVFHKDQFPFLPPLFSRWIPMSLLQHLPPAWHPEQLRRQLHSWLEDPADLEAALRQAGFTDTVITDEVVEMTAASGEDWVEWSHTQGMRLLWQHLPTDEAAALRTRLTGELDALRGADGLIRIDVPVRYVTATVAR	MFREMRRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPISYVYADGKIYFHSAMKGHKVDAILQNDKVSFCVVEQDDIRPSEFTTYFRSVIVFGKAHILTDELEKRVALGLLADKYSYGEAGMEAEIAKGFNHLLIVKIAIEHITGKEAIELTKNRNDRP	175.00	gnl|BL_ORD_ID|4791|hsp_num:0	5787			12	144	metronidazole
BGC0000952.1|Pristinamycin_27 # 54810 # 55667 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.740	BGC0000952.1|Pristinamycin_27 	54810	55667	+	Loose	700	26.5646	ADC-254	20.63	3006424	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGATTCTCGTCACCGGAGCGACCGGCAAAGTGGGCCGTGAGGCCGTGGAACAGCTCGCCGCGGCGGGCCGTCGGGTGCGCGCCCTGAGCCGTACCCCCGAGGAGGCGAACCTGCCGGCCGGCGTCGAGGTGGTGGCGGGCTCCCCCGCCGACCCGGCGTCGCTGGCCGCCGCGTTCCAGGGGGTGGACTCGGCGCTGGTGGTGCTGTCCGGCGATGTGGCGGGCGAGGCCCGCAACGTCGCCGCGGCCGCCGCGGCGTCGGGCGTCGGGCACCTGGTGTTCCTGTCGTCGGCGAGCGTGCTGCATCCGCTGCCGCACGGCATCGCGGACGAGCACCGGGCCGCGGAGGAGGCCATCACCGCGTCCGGCGTCGACACGACGTTCCTGCGTCCCGGCCCCTTCCACGCCAACACCTCGTGGTGGATCAGGACCGTGCGGGAGAGCGGCGCGGTGCGCTGCTGGATCGGCAACAACCCGGGTGCGCCGATCGACGAGTACGACATCGCCTCCTCTGCGGTGGCCGCGCTCACCGACGAGCGCCACCGGGGCAAGGCGTACGTGCTGACCGGTTCCGAGGTGCTGACCTCGAAGGAGCAGGCCCGCATCCTGGGCGAGGTCCTGGGCCGTGAACTGGACTTCTCCGTCGCGCCGCAGGAGGAGGTCGTGGAGGTCTTCGCGGGCATCACCGGCGACCGTCCGGCGGCGGTGACCAACGTGGCCGCCCTGCACAGCCCCGAGGTGCCGTGGGCCCGGCCGACGCCGGCGGTACGGCTGCTGACCGGCCGTGAGCCGCGCGGCTACCGGGCGTGGGCAGAGGCGAACGCGTCGCTGTTCGCCGCCGAGGAGGTGACGGTATGA	MILVTGATGKVGREAVEQLAAAGRRVRALSRTPEEANLPAGVEVVAGSPADPASLAAAFQGVDSALVVLSGDVAGEARNVAAAAAASGVGHLVFLSSASVLHPLPHGIADEHRAAEEAITASGVDTTFLRPGPFHANTSWWIRTVRESGAVRCWIGNNPGAPIDEYDIASSAVAALTDERHRGKAYVLTGSEVLTSKEQARILGEVLGRELDFSVAPQEEVVEVFAGITGDRPAAVTNVAALHSPEVPWARPTPAVRLLTGREPRGYRAWAEANASLFAAEEVTV	MRFKKISCLLLPSLFIFNTSIYAGTISKDQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSSTIFELGSVSKLFTATTGTYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPGEVQTDQQVLTFFKDWQSKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVTPGPLDAPAYGVKSTLPDMLNFIHANLNPQKYPADIQSAINETHQGFYQVGTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVSAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	74.41	gnl|BL_ORD_ID|3253|hsp_num:0	4320			18	207	
BGC0000952.1|Pristinamycin_28 # 55664 # 56539 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.721	BGC0000952.1|Pristinamycin_28 	55664	56539	+	Loose	375	28.4906	tmrB	27.55	3003059	protein homolog model	n/a	n/a	nucleoside antibiotic	reduced permeability to antibiotic	tunicamycin resistance protein	ATGAGCACCGGGGCCGGCGGTACGGTCCTGGTGACCGGTGCGACGGGCCTTCAGGGCGGGGCGACCGCGCGTGAACTGGTGCGCCGTGGGCGCACGGTGGCGGCGCTGGTGCGCGACCCGGCCTCCGAGGCGGCCCGGGCGCTGGCCGACCTGGGCGTGACGCTGGTGCGCGGCGACCTGGACGACGAGGCGTCGCTGCGTTCCGCGATGGAGGGTGTGCACGGGGTGTTCTCCGTGCAGACGTTCATGACGCCCAAGGGCCTGGGCGGCGAGGTCCGTCAGGGCCGCGCGGTGGCGCGTGCGGCGAAGGCCGCCGGCGTGGCGCACGTCGTGTACAGCTCGGTGGGCGGTGCGGAACGGCACAGCGGCGTACCGCACTTCGAGTCCAAGCGTCACATCGAGCGGTACCTGCAGGAGCTTTCGGTGCCGGTGACGGTGCTGCGTCCGTCGTTCTTCATGGACAACTTCGCCGCGCACGGTCCGCGACTCGTGGACGGGACGCTGGTGGTGCAGCTGGCGCTGAAGCCGGACACCCGCGTGCAGTTCATCGCCGTGGAGGACATCGGCTTCTTCGCCGCCGAGGCGTTCGAGCGGCCCGCCGAGTACGTGGGCCGTGCGGTGGAACTGGCGGGCGACGAGCTGAGCGCGAGGGAGGTCGCAGAGGCGTTCGCCGCGCGTACGGGTCTGCCGGCCCGGTTCGAGGAGCTGCCGCTGGACGCGGTGGCCGGGAACCCGTACATCCCCAACGCGCCGGAGATTGCGCTGATGTTCGAGTGGTTCCAGGAGCACGGCTACCGGGCGGACATCCCCGCGCTGCGCGCCGAGCACCCGGGGCTGCTGTCCTTCGCGGCGTACCTGAAGTCCCTGGACCTCTGA	MSTGAGGTVLVTGATGLQGGATARELVRRGRTVAALVRDPASEAARALADLGVTLVRGDLDDEASLRSAMEGVHGVFSVQTFMTPKGLGGEVRQGRAVARAAKAAGVAHVVYSSVGGAERHSGVPHFESKRHIERYLQELSVPVTVLRPSFFMDNFAAHGPRLVDGTLVVQLALKPDTRVQFIAVEDIGFFAAEAFERPAEYVGRAVELAGDELSAREVAEAFAARTGLPARFEELPLDAVAGNPYIPNAPEIALMFEWFQEHGYRADIPALRAEHPGLLSFAAYLKSLDL	MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK	147.72	gnl|BL_ORD_ID|1654|hsp_num:0	1794			228	513	tunicamycin
BGC0000952.1|Pristinamycin_29 # 56753 # 57637 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.731	BGC0000952.1|Pristinamycin_29 	56753	57637	+	Loose	500	27.335	OXA-780	33.33	3005983	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCAACGGCCCATCATCGCCGGAGTTGACGGCAGCTCCGACAGTCTGATCGCAGCGGGCTGGGCGGCCGGCGAGGCACGGCGGCACGGGGCGCCCCTGGTGCTGCTGCACGGTCATGTTCCGCAGGCGGGGTTCTACCGGGTGCTCGCCGGCGACATCGAGCACGAGCGCCGCGCGGCGCGGCAACTGCTCGATGACGCCCTGGCTTGGGTGCGCGAACACTTCGAGGACGTCGAGGTGAGTGCCGAGCTGGTGGTGAAGCCGGAGGCGGAGCTGCTTGTCGAGCGCGGCCGGAACGCGCGGATGATCGTGCTCGGCTCCCGGCGGCCGGGCCCGGTGACGGGCTTCTTCCTCGGATCGGTCGGACTTCGCGTGCTGAGCAGAGCCGCCTGCCCCGTGGTCATGATCCGCGGCGGCTCGGCCGGCCGCCGGCCGCGGGACGGCGAGATCGTGGCCGGTGTCCCCCGGGAGGAGGAGGCCGAGGCGGTCCTGGACTTCGCCTTCCGGGCCGCCGCCGCGCGCGGTGTGCCGCTGCGCGCGGCGCGCGCCTGGAGCCTGCCCACCATGTTCACCCACGAGCCCGAGCTGTCGCGCCGCGCGAACGAGCACGGTGGGCTGGAGGAGGTCCACCGCCATGACCTCGCGAACCTGCTGGCGCCGTGGCGTGAGCGCCATCCGCAGGTCACGGTGGTGGAGCATGTCGAACCGAGTCCGACCGCCGAGATGCTGGTGAGTCTGGCGGCCTCTGCCCAGCTCCTCGTCGTCGGCCGCCGCGCCGAACCCCGCAGCCGTTATGTGGGCCATGTCGCCCACGCGACCCTCCACTTCGCCGACGCGCCCATCGCCCTCATTCCTCATCCGCTGGACGCGGCCGCCGACGGGTGA	MQRPIIAGVDGSSDSLIAAGWAAGEARRHGAPLVLLHGHVPQAGFYRVLAGDIEHERRAARQLLDDALAWVREHFEDVEVSAELVVKPEAELLVERGRNARMIVLGSRRPGPVTGFFLGSVGLRVLSRAACPVVMIRGGSAGRRPRDGEIVAGVPREEEAEAVLDFAFRAAAARGVPLRAARAWSLPTMFTHEPELSRRANEHGGLEEVHRHDLANLLAPWRERHPQVTVVEHVEPSPTAEMLVSLAASAQLLVVGRRAEPRSRYVGHVAHATLHFADAPIALIPHPLDAAADG	MPRMLLSGLLAAGLFCALPASAASGCMLFADGTGKPVSTQGDCAAQLTPASTFKIPLALMGYDSGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSSWMKNSVIWYSQRLTEWLGEARFQHYVDSFDYGNRDLEGNPGKHDGLTQAWLSASLAISPQEQARFLGKMVSGKLPVSAQTLRHTANLMRQPDIDGWQIHGKTGMGYPKLLDGSLDREQQIGWFVGWASKQGKTLIFVHTVIQKPGKQFASLRAREEVFAALPARLKTL	111.36	gnl|BL_ORD_ID|4018|hsp_num:0	5088			615	723	cloxacillin; oxacillin; cefalotin
BGC0000952.1|Pristinamycin_30 # 57906 # 58430 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.730	BGC0000952.1|Pristinamycin_30 	57906	58430	-	Loose	1100	25.409	oleB	57.89	3003036	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGACCCACCGCACGTCGAGCCGTCCTCCGTGCGTCGTGATCTCCGGAGTGTCCGGGGCCGGGAAGTCGACGGTCGCCCGGCAGCTGGCCGAGCGTCTGGGGGTGCCCTTCGCCGAGGCGGACGACTTCCACTCGCCCGACAGCATCCGGAAGATGGCGTCGGGAGTTCCGCTGGACGATCGGGACCGCCGGGCGTGGCTGGAGTCCGTCGGACGCTGGCTGGGCGACCGCGACGCCGCCGGCAGCGGGGGAGTGGCGTCCTGCTCCGCCCTGCGGCGGCGTTACCGGGACATCCTGAGGTCGGCCTGCCCCGCCGCGGTCTTCTTCCAGCTCACCGCCGACCGCGAGGTGCTCGCGGGCCGGCTCGGCGGGCGCAGGGGCCACTTCATGCCGCAGACCCTGCTCGACTCCCAGCTCGCCACGCTCGAGCCGCTCGAACCGGACGAGAGGGGAGCCTCGTTGGATGCCTCACCGGCTCCCGAGGAGATCGTCCGGACGGCCGTGAAGCTGCTCGACGGACGCTGA	MTHRTSSRPPCVVISGVSGAGKSTVARQLAERLGVPFAEADDFHSPDSIRKMASGVPLDDRDRRAWLESVGRWLGDRDAAGSGGVASCSALRRRYRDILRSACPAAVFFQLTADREVLAGRLGGRRGHFMPQTLLDSQLATLEPLEPDERGASLDASPAPEEIVRTAVKLLDGR	MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGERVGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHALAELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGLAGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGSVLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDLARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPPQPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLLRVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGLFRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRGALVVVSHDRMFAQRFTGRRMHMEGGRFVE	30.58	gnl|BL_ORD_ID|1272|hsp_num:0	1388			1215	1272	oleandomycin
BGC0000952.1|Pristinamycin_31 # 58493 # 59920 # -1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0000952.1|Pristinamycin_31 	58493	59920	-	Loose	500	27.335	OXA-34	26.5	3001428	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCATCCGACGACTCGTCGTCTTCGGCGGGACAGGCGACCTCACGGGCCGCTTCCTGCTGCCGGCGCTGGCCGCCCTGCACGCGGCGGGACACATCGACGACCGGTTCGGCCTGACGGGCGCCAGCCGGGAGGACTGGGACGGCGAACGGTACCGGAAGTGGGCCGACGCCCAGCTCGAACGCCACGGCGCCGACCTCCCTGCCGACTCCCGGCGAGCCGTCATCGCGTCGGCCGACTACCGCAGGGCCGACGTGACGGACCCCGCGGACGTGGGCGCGGCCGTCGCCGGTGAAGACCCCGTGGCCGTCTACCTCGCGCTCCCCCCGGCGCTGTTCCCGGCGACGGTGACCGCGCTGCACGAGGCCGCACTGCCCCCAGGCAGCCGCATCGTCCTGGAGAAGCCGTTCGGCGAGGACCTCGCCGGCGCACAGGAGTTGAACCGGCTGCTCGCCGATCTCGTACCCGAGCGCGCCGTCTTCCGGGTCGACCACTTCCTGGCCATGACGACCGTTCAGAACGTCCTCGGCAGCAGGCTCGCCAACCGGGTCCTCGAACCCATCTGGAACAGCACGCACATCGCCGAGATCGAGATCGTCTGGGACGAGACCCTCGCCCTGGAAGGGAGGGCCGGCTACTACGACCACGTCGGCGCGCTGAAGGACATGGTGCAGAACCACCTGCTGCAACTGCTGTGCCTGGTCGCCATGGAGCCGCCGCTCACCCTCGGCGAGCGGGACCTGCGCGACCGGAAGGTCGACGTGCTGCGGTCGGTGCGGCCGCTGACCGACTTCGACGTCGCGCACCGCACGCGCCGCGCCCGCTACTCGTCCGGCCGGGCCGGCGACCGCGAGGTGCCCGCCTATGTGGACGAGGACGGTGTCGACGCGCGGCGCCGGACCGAGACCTTCGCCGAGATCGTGCTGGAACTGGACAGCTGGCGCTGGACGGGCACCCGGTTCCGTCTGCGCAGCGGCAAGGGCCTCGGCAAGGACCGCAAGGAGGTCGCGGTGCACTTCCGTTCCGTACCTCACCTGCCCTTCGGACAGGACAAGGACGTCCGGCCCAACGTGCTGCGGTTCGGCCTGGAACCCGAGAGCCTGAGCATGGACATGACCGTGACGGGCTCGCGTGCCGAGACCCTCACCCAGCTCGCGCTGACCGCCGAGATGGACGCCCCCGCCCTGCCGGCCTACGGCCGTCTGCTGCTGGACGTTCTGGGCGGCGACCCCGCGCTGTCCATCCGCAGCGACGAGGCCGAGGAGGCCTGGCGTGTCGTCGAACCGGTCCTGTCCGCCTGGGAGCGGGACCTGGTGCCCATGGAGGAGTATCCGGCCGGCTCGGACGGGCCGCCCCCACGCCACACCACCCCTGGACGGCGGGACGACCTGCTCCACGAGGAAGCCGTCATGCCGGCCGACTCCTGA	MTIRRLVVFGGTGDLTGRFLLPALAALHAAGHIDDRFGLTGASREDWDGERYRKWADAQLERHGADLPADSRRAVIASADYRRADVTDPADVGAAVAGEDPVAVYLALPPALFPATVTALHEAALPPGSRIVLEKPFGEDLAGAQELNRLLADLVPERAVFRVDHFLAMTTVQNVLGSRLANRVLEPIWNSTHIAEIEIVWDETLALEGRAGYYDHVGALKDMVQNHLLQLLCLVAMEPPLTLGERDLRDRKVDVLRSVRPLTDFDVAHRTRRARYSSGRAGDREVPAYVDEDGVDARRRTETFAEIVLELDSWRWTGTRFRLRSGKGLGKDRKEVAVHFRSVPHLPFGQDKDVRPNVLRFGLEPESLSMDMTVTGSRAETLTQLALTAEMDAPALPAYGRLLLDVLGGDPALSIRSDEAEEAWRVVEPVLSAWERDLVPMEEYPAGSDGPPPRHTTPGRRDDLLHEEAVMPADS	MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFDPVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYCIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAIL	184.82	gnl|BL_ORD_ID|1552|hsp_num:0	1686			447	765	cloxacillin; oxacillin; cefalotin
BGC0000952.1|Pristinamycin_32 # 59917 # 60126 # -1 # ID=1_32;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0000952.1|Pristinamycin_32 	59917	60126	-	Loose	250	23.8682	DfrA37	23.91	3005347	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGGAGAACCTGACCGGTCGGGGCCGCCTCGACGAGGCCGGAGAACTGTACGCGTCGCTGTGCTCCGAGCGAGCCCCCCTGGGGCTGCTGCCGGAGCAGATCGACCCGACCACGGGAGCATTCATGGGCAACTTCCCCCAGGCGTCCGGCCGCCTCGGCGTCATCGCCGGCGGAGCCGGCCTCGCACGGGCGCAGGGCGGTTCGCGATGA	MENLTGRGRLDEAGELYASLCSERAPLGLLPEQIDPTTGAFMGNFPQASGRLGVIAGGAGLARAQGGSR	MKLSLMAAISRNGVIGNGPDIPWSAKGEQLLFKAITYNQWILVGRKTFESMGALPNRKYAVVTRSNFTSDNENVIVFASIQDALSQLENMTNHVIVSGGGEIYKNLIDKVDTLHISTIDIEPEGDVYFPEIPSNFRPVFIQDFVSNINYSYQIWQKG	43.95	gnl|BL_ORD_ID|3053|hsp_num:0	4079			258	396	trimethoprim
BGC0000952.1|Pristinamycin_33 # 60179 # 61339 # -1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.679	BGC0000952.1|Pristinamycin_33 	60179	61339	-	Loose	660	44.669	MexS	29.74	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCCTGGAGCAGTTGCTTGCGCCGCGGACGGCACGCGGCGGCGCGATCCGTGTACCGATGGCTCAGCGTTTTCCCCTGACCGGGAAGAGCCGGCAGGAGGACGAAACAGTGCGGGCATTTGTCATGAAGGAAATCGGCAAAGTGGCTTTCATGGACAAGCCGGTCCCCGACGTCGGCTCCCGTGACGCCCTGGTGCGGACGACGAAGGCCCTGATCTGCACCTCCGACTCCCACACGGTGCAGGGAGGCATCGGACCGCGGGAAGACCTCACGCTGGGGCACGAGGCGGTCGGCGTCGTGGAGTCCGTGGGCAGCGACGTGAAGGACTTCCGGCCGGGCGACCGTGTCCTCGTCGGCGCCATCACCCCCGACTGGGGCGACCTGGCCTCCCAGAACGGCCACCCGTCCCAGTCGGGCGGACCGCTCGGGGGATTCAAGTTCGCGAACCTGAAGGACGGCGTGTTCGCCGAGTTCTTCCATGTCGGTGACGCCGACGCCAACCTCGCGAAAATCCCCGACAGGATCCCCGACGAAGCGGCCGTCTACTGCGCCGACATGCTTTCCACGGGATTCATGGGCGCCGAACACGGCAACATCCCGATGGGCGGGACCGTGGCCGTTCTCGCCCAGGGCCCCGTGGGACTGATGGCGACGGCAGGGGCCCGACTCCTGGGCGCGGGACTCGTCATCGGCGTCGAGTCCGTGCCGAGCCGGCAGGAACTCGCGCGCCACTACGGAGCGGACGAGATCGTCGACTTCACCCACGAGGACGTGACCGAACGCGTTCTCGAACTGACCGGCGGCCAGGGGGTGGACACGGCGATCGAGGCGCTCGGCGCGGACGTCACCTTCAGGACCTGCGTCGAGATCACGAAGCCCGGCGGCACGATCTCCAACATCGGCTACTTCGGCTCCGGCGACCACGTCAGCATTCCCCGCGTCGCCTGGGGCGTCGGCATGGCCGACAAGACGATCGCCTCCGGCCTCTGCCCCGGCGGAAGGCTGCGGATGGAGCGCCTGCTGCGCGTCCTGGAGAAGGGCCGCCTCGACCCCACGCGCATGACCACCCACACCTACTCCTTCGACGAGATGGAACGCGCCTTCGAGGTGTCGGACAAGAAGCTGGAGGACGTCGTCAAGGTGCTGGTGAGCTTCTAG	MSLEQLLAPRTARGGAIRVPMAQRFPLTGKSRQEDETVRAFVMKEIGKVAFMDKPVPDVGSRDALVRTTKALICTSDSHTVQGGIGPREDLTLGHEAVGVVESVGSDVKDFRPGDRVLVGAITPDWGDLASQNGHPSQSGGPLGGFKFANLKDGVFAEFFHVGDADANLAKIPDRIPDEAAVYCADMLSTGFMGAEHGNIPMGGTVAVLAQGPVGLMATAGARLLGAGLVIGVESVPSRQELARHYGADEIVDFTHEDVTERVLELTGGQGVDTAIEALGADVTFRTCVEITKPGGTISNIGYFGSGDHVSIPRVAWGVGMADKTIASGLCPGGRLRMERLLRVLEKGRLDPTRMTTHTYSFDEMERAFEVSDKKLEDVVKVLVSF	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	113.86	gnl|BL_ORD_ID|1039|hsp_num:0	1041			96	669	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000952.1|Pristinamycin_34 # 61440 # 62486 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.738	BGC0000952.1|Pristinamycin_34 	61440	62486	+	Loose	500	28.8758	LpsA	25.56	3005052	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGAACGGCACGGTGCCCCTGAGGGCTTTCATCGGTTGCTTTACAACAAATGGGGGACGGGGAATCGTCCGGGCCGCGGTGGATCCGCGCACCGGGGCGCTGACCGCGGAAGGCACCGTCGAGACCGTTCCCGACCCGTCGTATCTGGCTGTGGGACACCGGGGAAGCGGCCCGGTTCTCTACTGCGTGTCCGAAACGGCCCACGGGGCGGTCGCCGGCTTCGACGTCTCGGGGCCGGTGCCCCGGCCGCTCGGCGAGCCCGTTGCGACAGGAGCGGCCGACCCGACGCACCTCGCCGTCTGCCACGACCACCTGGTGACGGCGGACTACGGGTCCGGGAGCGTCACCGTGCTGCCGCTGGCCGCCGACGGCAGCCCCCTCGCGCCGAGCAGCGTGCTGCGCCACGAGGGGTCCGGGCCGGACCGGGAACGCCAGTCGGCCCCGCACGCCCATCAGGTGGTCCAGGATCCTTCGGGAGGCTGGGTGCTGAGCGTCGACCTCGGCACCGACTCGGTGCGGGTCTGCTCCCTGGACCCGGGCACCGGGCAGCTCGCCCTCCACAGCGTCATGGACCTGCCGCCGGGCACGGGCCCGCGCCACCTCGTCTTCCACCCGCGCGGCAGCCACGCCTACGTGCTCGGTGAGCTGCGGCCCACCGTCACCGTGTGCCGCTGGGACGCGGCCTCGGGCGTGCTGCTGCCGGTCGGTGAGTTTCCCCTCTTCCCGGACGGCGCCGGCGTTGCGGTGCAGCCCTCCGCGCCCGTCGTCTCCCGGGACGGGCGGCATCTGTGGGCGGCCGTCCGCGGCACCGACACCATCGAGGTCCTCTCGCTGGACGAGACGGGCGAGGTGGCACGGGTCGTCACCTCGGTGCCGTGCGGAGGCCACTGGCCGCGCGACCTCGTACTGCACCCGTCGGGCGCCCACCTGTACGCCGCCAACGAGCGTTCGGGCGATGTGACCTGGTTCGACGTCGACGCGACGGGGGTGCCGCGCCGAGCCGGGTCACTCGCCGTGCCGGCGGCGTCCAGCGTCGCCTTCGCCTGA	MNGTVPLRAFIGCFTTNGGRGIVRAAVDPRTGALTAEGTVETVPDPSYLAVGHRGSGPVLYCVSETAHGAVAGFDVSGPVPRPLGEPVATGAADPTHLAVCHDHLVTADYGSGSVTVLPLAADGSPLAPSSVLRHEGSGPDRERQSAPHAHQVVQDPSGGWVLSVDLGTDSVRVCSLDPGTGQLALHSVMDLPPGTGPRHLVFHPRGSHAYVLGELRPTVTVCRWDAASGVLLPVGEFPLFPDGAGVAVQPSAPVVSRDGRHLWAAVRGTDTIEVLSLDETGEVARVVTSVPCGGHWPRDLVLHPSGAHLYAANERSGDVTWFDVDATGVPRRAGSLAVPAASSVAFA	MHNAAQHNYVISLTTEQKRRKHITEEFGKQNIPFEFFDAITPDIIEETAKKFNITLDRSPKAKLSDGEIGCALSHIVLWDLALENNLNYINIFEDDIHLGENAKELLEIDYISDDIHVLKLEANGKMFFKQPKSVKCDRNVYPMTVKQSGCAGYTVTAKGAKYLLELVKNKPLDVAVDSLVFEDFLHFKDYKIVQLSPGICVQDFVLHPDNPFESSLQEGRDRVHGNQRKFSILEKIKNEFGRVKIKMFGKQVPFK	135.94	gnl|BL_ORD_ID|2782|hsp_num:0	3794			282	672	polymyxin B; defensin
BGC0000952.1|Pristinamycin_35 # 62576 # 63670 # -1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.737	BGC0000952.1|Pristinamycin_35 	62576	63670	-	Loose	550	26.1794	AAK-1	29.73	3006863	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	AAK beta-lactamase	ATGGATCTTGCGTTTCTTCAGCCCCTGTACGAGGGCGAGGGCCCCGTCGCCTCCGTCCACCTGGACACGAGCCGTTCGGCGCACGACGCCGACAAGCAGATCGAGCTGCGCCGGCGCGCCGCGCTCCGGTCACTGGCCGAACAGGGCGCGGACCAGGCGACGCTGGACGTGCTGGAGCAGATGATCGGAGGCGTCGCCGAGGTGCCGGGGCCTCAAGGGGAGGCCCTGTTCGCATCGGCCGGGCGGCTTCTCGGAGCGTTCACCCTGACGGAGCCGCCCGCGGCCGACAGCGCGCTGTTGCTGCCCGTGCCCGACCCGCTGGGTCTGGTGATCGACCGGGACCATCAACTGCCGCACGTCGTCGTCGCCGTCGACCGCGAGGGAGGGGATGTGACCGCCTACCCCGCCGCAGCGCACGAGCCGTCCATGAAGCGCACCTTCAACGGCAGCACGCTGCACATCAGCCGGGTGAAGGCGGGCGCGGAGGCCCAGGCCTCCTTCCACCGGCGGTCGGTCAACGTGTGGAGCGAGAACACCGAGCAGACCGCCGACGACGTGCGCGAAGCGGCAGCCGGCGTGGAGGCCGCGGTGGTCCTGGTCGCCGGGGACCCCAAGGCGATCGGGCTGCTGCGCGAGCACCTGACGGACCAGCCACCGGTCGGGGAACTGGTCTACGTGGACGGAGGCCGCAGCGACACCTCGGCCCTCGCAGGTCTGCGGGCGAGCGTGGACGCGGCGATGCGCGAAGCCATGACCGCCCGTCACCGCGGCGTCCTGGACACCCTGGAGGCCGAGCTGGCCGGCGGGCGGGCCCTGCAGGGGATCCCGGCCGTGAAGGAGGCGCTGGCACAGGGCCGGGTGGAGACACTGCTGCTCGCCGCGGACCGCTCCGGCGACCCGGTCCTGCACGCCTCGCGCCGCGATCCCCAGGTGCTGGGCACCGACCCGGCGGCGCTGGGCGACGACCCGACGGTGTTCAGCGCGCCCGCGGCGCCGCTGCTGCTGCGCGCGGCCGCTCTGGGCGGTGCCGCCTTCACCGAGATCCTGCCGCCTGCCCGTGCGACGGACGGTGTGGCCGCCCTGCTGCGGTACTGA	MDLAFLQPLYEGEGPVASVHLDTSRSAHDADKQIELRRRAALRSLAEQGADQATLDVLEQMIGGVAEVPGPQGEALFASAGRLLGAFTLTEPPAADSALLLPVPDPLGLVIDRDHQLPHVVVAVDREGGDVTAYPAAAHEPSMKRTFNGSTLHISRVKAGAEAQASFHRRSVNVWSENTEQTADDVREAAAGVEAAVVLVAGDPKAIGLLREHLTDQPPVGELVYVDGGRSDTSALAGLRASVDAAMREAMTARHRGVLDTLEAELAGGRALQGIPAVKEALAQGRVETLLLAADRSGDPVLHASRRDPQVLGTDPAALGDDPTVFSAPAAPLLLRAAALGGAAFTEILPPARATDGVAALLRY	MRYIRLCIISLFATLPLAVHASPQPLQQITLRESQLSGRVGTIEMDLASGRTLTAWRADQRFPIMRTFTVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMPVGELCAAAITISDTSAANLLLATVGGPAGFTAFLRQIGDNVTRLHRWETELHAALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLLRSVLPAGWFIADKTGAGERGARGIVALLGPNHKAERIVVIYLRDTPASMAERNQQIAGIGAALLEHWQQ	127.27	gnl|BL_ORD_ID|3091|hsp_num:0	4122			66	414	
BGC0000952.1|Pristinamycin_36 # 63920 # 64378 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.725	BGC0000952.1|Pristinamycin_36 	63920	64378	+	Loose	1300	25.409	optrA	42.86	3003746	protein homolog model	n/a	n/a	oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGCTGACCAGCGCGAGGAGACGGGCCGCATCGTGGTCGGAGTGGACGGTTCGGACTCGTCGAAGCAGGCCCTTCGCTGGGCCGTGCGTCAGGCGGAGGCCACCGGCGGTGTGGTGGAGGCGGTGACCGCCTGGGACTTTCCGCAGTTCCACGGCGCGCTCGGCTGGCTGCCCCCGTCGAGCGGCGACGAGGCCGCGCTGGAGGCCCGGGCACGCAAGGAACTCGACGAAGCCGTCGAGGAAGCCGTGGGATCGCAGCCGCCGGTGGAGGTACGCAGCGAGGTGCGTTACGGCACCCCGGCCAGTGTGCTGCTGAACGCGGCCCACGGCGCGACCTTGCTCGTGGTCGGCAGCAGGGGCCTCGGCGGCTTCGCGGGGCTGCTGTTGGGCTCGGTGGCCCAGCACTGCACCCAGCACGCCGCATGCCCGGTCCTCGTGCTCCGCGGCGACAGCCAATGA	MADQREETGRIVVGVDGSDSSKQALRWAVRQAEATGGVVEAVTAWDFPQFHGALGWLPPSSGDEAALEARARKELDEAVEEAVGSQPPVEVRSEVRYGTPASVLLNAAHGATLLVVGSRGLGGFAGLLLGSVAQHCTQHAACPVLVLRGDSQ	MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKTTLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPISEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQISGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKRTNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM	23.21	gnl|BL_ORD_ID|2069|hsp_num:0	2263			1062	1188	linezolid; chloramphenicol; florfenicol; tedizolid
BGC0000952.1|Pristinamycin_38 # 65189 # 65641 # -1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.664	BGC0000952.1|Pristinamycin_38 	65189	65641	-	Loose	575	28.8758	PLA-3	40.91	3006970	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	PLA beta-lactamase	ATGACCGCAACACTCGCCGAGCAGCCCGCCGTCACCGTCCAGGAGCGCAACAAGCAGATCGCGCTGGACTGCGCCGCCGCCTGGAACCGCTGGGACCTGGACGGGATCTTCACGCACTGGTCGCCGGACATCAAGCACTTCTCCGAGGACCGCCCGGTCGACTCCGAGATCATGAAGGCCGCGATGCGCGGCGGACTCGCCGCCTTCCCGGACCTGCACCTGGACGTCAGGAGCGCCGTCTCCGAAGGCGACCGCGTCATCCTGCGGATCACCGTGACCGCCACCCACCGGGGCGACTTCTTCGGCAAGGCCGCGACCGGCAAGAAGGTCACCTGGTTCATGCTCGAGGAGCTGCGCTTCGACGACGCCGGAAAGATCATCGAGCACTACGACGTCTTCAACTACCTGCCGATGCTCAAGGAGCTGGGCTTCGTCGCCGCCGACGTCATGTGA	MTATLAEQPAVTVQERNKQIALDCAAAWNRWDLDGIFTHWSPDIKHFSEDRPVDSEIMKAAMRGGLAAFPDLHLDVRSAVSEGDRVILRITVTATHRGDFFGKAATGKKVTWFMLEELRFDDAGKIIEHYDVFNYLPMLKELGFVAADVM	MRQYRFALLPLLAALALPGWAHQATVTTVKQAESQLQGRVGYAELDLASGQLLAGYRSDERFPMMSTFKVLLCGAVLSRVDAGEEQLDRRIHYRQQDLVEYSPVTEKHLTDGLTVGELCAAAITLSDNTAANLLLTTLGGPQGLTSFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPQAMARTLRNLLTGRVLSSASQQQLQRWMVEDKVAGPLLRSVLPAGWFIADKTGAGNRGSRGIIAALGPDGKAARIVVIYLTGPPATMDERNKQIAAIGATLVTHWSADENRP	51.55	gnl|BL_ORD_ID|4557|hsp_num:0	5627			783	873	
BGC0000952.1|Pristinamycin_39 # 65660 # 66337 # -1 # ID=1_39;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.748	BGC0000952.1|Pristinamycin_39 	65660	66337	-	Loose	660	29.261	MexS	28.8	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GATCGCCTTGGAGCGGCCGTCGCCGTCTCCCTGATCACCAACGGTGTGACGGCCTACCAGATGCTGCACCGGCAGACCCGGCTCGCCGCCGGCTCCACCGTGCTCGTGCACGGCGCCAGCGGCGGCGTGGGCACCCTGCTCACCCAGCTCGCCGTCCACGCGCAGCTGCGCGTCATCGGCACCGCCTCACCCGCCAAGCACCCGGCGGTGCGCGCGCTGGGCGCGGAACCCCTCGACTACCGCACCGAGGACCTGCCCGCCGCCGTACGGGAACTGGCACCCGACGGCGTCGACGCCGTCTTCGACCACATCGGCGGACGCGGCCTGGACGCCGGCTGGGCCATGCTCGCCGACGGCGGCACCCTCGTCTCGTTCGACTCCTCCGTGGCCGGCTACCGGCCCGGTCAGTGGTTCAGGCCGCACGTGCCCGCACTGCGCCGCACCGCCGCCCGCTGGATCGCGGCCAAGCTCCGCCTCACCCGCGGCCGCCGCCAGAGCATGTACTACGTCAAACCCGGCGACGACTTCCGGGCCGACCTCGCCGCGCTGTACCGGCTGGTCGACGAGGGCGTCCTGCGCCCCGAGATCGCCGGCCGCCATCCGCTGACCGAGGCCCCGGCCGCGGTCCGCGCCCTGCTGGACGGCGCCACCGTCGGCAAGCACGTCCTGATCCCCTGA	DRLGAAVAVSLITNGVTAYQMLHRQTRLAAGSTVLVHGASGGVGTLLTQLAVHAQLRVIGTASPAKHPAVRALGAEPLDYRTEDLPAAVRELAPDGVDAVFDHIGGRGLDAGWAMLADGGTLVSFDSSVAGYRPGQWFRPHVPALRRTAARWIAAKLRLTRGRRQSMYYVKPGDDFRADLAALYRLVDEGVLRPEIAGRHPLTEAPAAVRALLDGATVGKHVLIP	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	66.37	gnl|BL_ORD_ID|1039|hsp_num:0	1041			426	801	ciprofloxacin; trimethoprim; chloramphenicol
